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Transcriptional Dynamics of Normal and Hand2-deficient Cardiogenesis 
at Single-cell Resolution 




Organogenesis involves integration of myriad cell types, each progressing through 
successive stages of lineage specification, proliferation and differentiation. Establishment 
of unique gene networks within each cell drives fate determination and behavior, and 
mutations of the transcription factors that drive such networks can result in birth defects. 
Congenital heart malformations are the most common defects, and are caused by 
disruption of discrete subsets of progenitors that contribute to distinct cardiac structures. 
However, determining the transcriptional changes in individual cells that lead to organ-
level defects in the heart has not been tractable. Here, we employed single-cell 
transcriptomics to interrogate early cardiac progenitor cells as they become specified 
during normal and abnormal cardiogenesis. We identified novel cell-type specific genes 
and uncovered additional heterogeneity within wild-type progenitor compartments. A 
network-based computational method that predicts lineage specifying transcription 
factors identified Hand2 as a specifier of outflow tract cells but not right ventricular cells, 
despite failure of right ventricular formation in Hand2-null mice. Temporal single-cell 
transcriptome analysis of Hand2-null embryos revealed failure of outflow tract 
myocardium specification, whereas right ventricular myocardium was appropriately 
specified, but exhibited differentiation defects and failed to migrate into the developing 
heart. We found dysregulation of retinoic acid signaling that was associated with 
 ix 
posteriorization of anterior cardiac progenitors in Hand2-null mutant hearts and ectopic 
atrial gene expression in outflow tract cells and right ventricle precursors. This work 
reveals transcriptional determinants in individual cells that specify cardiac progenitor cell 
fate and differentiation, and exposes mechanisms of disrupted cardiac development and 
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1.1 Congenital Heart Defects 
 
Congenital heart defects (CHDs) are malformations of the heart and great vessels that 
arise due to disrupted embryonic cardiac development1,2. They encompass a wide 
spectrum of abnormalities that manifest in diverse cardiac structures and display a broad 
range in severity. CHDs are considered a major cause of fetal demise and are the most 
commonly occurring birth defect worldwide, affecting millions of newborns annually, with 
increasing global prevalence3,4. Recent advances in prenatal diagnosis, corrective 
surgical strategies and long-term care have resulted in over 75% of CHD patients who 
survive to adulthood3. While this represents a major clinical advancement, these patients 
remain at risk for late complications, such as cardiac arrhythmias, endocarditis, 
pulmonary hypertension, heart failure, neurodevelopmental deficits and other congenital 
abnormalities1,5. Thus, understanding how the molecular and cellular pathways 
underlying cardiac development are disrupted in these patients is critical for designing 
intervention and therapeutic strategies for the long-term sequelae of their CHDs6. 
Known non-genetic causes of CHD include environmental teratogens (i.e., pesticides 
and retinoic acid), maternal exposures (i.e., alcohol, maternal diabetes and 
phenylketonuria) and infectious agents (i.e., rubella)1,3 and account for roughly 10% of 
CHD cases2. Defects in single genes account for 3-5% of CHD cases and include loss of 
function of core cardiac transcription factors such as NKX2.57, GATA48, MEF2C9, TBX510 
and TBX110. Aneuploidies, copy number variations and de novo single nucleotide variants 
account for 33% of CHD cases, which include CHDs arising from malformation 
syndromes such as Down syndrome, trisomy 13, trisomy 18, Turner syndrome and 
DiGeorge syndrome1,2,5. The genetic underpinnings of over 50% of CHD cases remain 
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unknown. Collaborative efforts to map genetic variants associated with the disease are 
underway, aided by advances in sequencing and genomic technologies5. However, many 
of the genes in which CHD-linked mutations have been identified are novel, with unknown 
function and expression dynamics in cardiogenesis. Dissecting how such genes function 
in cardiac development in model organisms and with stem cell based cardiac 
differentiation systems is critical for understanding how their damaging variants could 
leads to CHDs.  
 
1.2 Early mammalian cardiogenesis  
 
A salient feature of most CHDs is that distinct structures of the heart are malformed, 
while the rest of the organ develops appropriately11. This reflects the integration of 
regionally and molecularly distinct cell types, that are specified from multiple progenitor 
domains, in assembling discrete structures of the embryonic heart. Indeed, embryonic 
cardiogenesis is an intricate process involving diverse cell type specification events, 
reciprocal cell-cell interactions and complex morphogenetic changes.  
Work in model organisms such as the chick, frog, zebrafish and the mouse have 
revealed the molecular and cellular pathways underlying cardiogenesis12. The origins of 
the heart, which is the first organ to form in embryonic development, can be traced to the 
early gastrulating embryo. At this stage, which occurs at mouse embryonic day (E) 6.0, 
gastrulating mesoderm is rapidly sub-specified to committed Mesp1+ precursors fated for 
specific anatomical locations in the heart13,14. These precursors leave the primitive streak 
at the dorsal region of the developing embryo and migrate towards the antero-lateral pole 
to form the lateral plate mesoderm (LPM)15. As they migrate and form the LPM, the 
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cardiac precursors are closely apposed to the anterior endoderm, which secretes signals 
such as Bone morphogenetic protein (Bmp)-2, Bmp-4 and Fibroblast growth factor (Fgf)-
8 to induce their cardiogenic gene expression12.  
At E7.5 in the mouse, which corresponds to week 2 of human gestation, the first visible 
cardiac structure forms, resembling a crescent6. This cardiac crescent comprises 
progenitor cells described as the first heart field (FHF), with a second progenitor 
population called the second heart field (SHF) located medially and more posteriorly16. 
The FHF is a rapidly differentiating progenitor population that is marked by the potassium-
channel subunit encoding gene, Hcn417, while SHF cells, defined by Isl1 and Tbx1 
expression18,19, remain in a prolonged progenitor-like state, likely because they are 
exposed to inhibitory Wnt signals emanating from the embryonic midline6,20,21. The SHF 
is also patterned along the anterior-posterior axis into two molecularly distinct domains 
that give rise to specific cardiac structures, the anterior heart field (AHF), that expresses 
genes such as Fgf8 and Fgf106, and the posterior second heart field (pSHF), marked by 
Nr2f2, Tbx5, and Wnt216. At E8.0, corresponding to week 3 in human development, the 
FHF cells migrate and fuse at the ventral midline to form a primitive heart tube, the 
presumptive left ventricle (LV), that begins to beat and consists of an inner layer of 
specialized cardiac endothelial cells, the endocardium, and an outer layer of myocardial 
cells. Between the two layers lies an extracellular matrix mainly composed of hyaluronan 
and chondroitin sulfates called the cardiac jelly6,22. Concomitantly, the SHF cells relocate 
dorsally into the pharyngeal mesoderm and begin to migrate into the heart at the arterial 
and venous poles, contributing to the majority of heart growth and chamber formation. 
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The AHF cells form the presumptive outflow tract (OFT) and right ventricle (RV) chamber, 
while the pSHF cells give rise to the atria and sinus venosus (SV)16.  
At E8.5, the heart breaks symmetry and undergoes rightward looping23, to distinguish 
and align the RV and LV chambers. By E9.5, which is week 4 of human gestation, the 
heart comprises the two ventricles, a common atrial chamber, the atrioventricular canal 
(AVC), SV and OFT. At this stage, neuroectoderm-derived cardiac neural crest cells are 
migrating from the dorsal neural tube into the pharyngeal arches and the OFT at the 
arterial pole of the heart in response to OFT-derived guidance cue signals24–26. After they 
invade the OFT, these cells differentiate into smooth muscle cells and remodel the OFT 
to form the base of the pulmonary artery and the aorta; this enables blood from the 
ventricles to enter the systemic versus pulmonary circulation. Formation of the cardiac 
valves, which are affected in 20-30% of congenital heart defects22,27, is also in progress 
at this developmental stage. To form these structures, the endocardial cells underlying 
the OFT and AVC undergo an endothelial-to-mesenchymal transition (EndMT) in 
response to Bmp4 and Bmp2 signals secreted by the overlying OFT and AVC 
myocardium, respectively. These prospective valve endothelial cells migrate into a bulge 
of cardiac jelly, called the endocardial cushions, to populate it with mesenchymal cells. 
Additionally, the transient proepicardial organ, comprising a population of cells that will 
begin to migrate over and sheathe the myocardium in a layer of epicardium, emerges at 
this stage28. A subset of these epicardial cells will later invade the underlying myocardium 
and give rise to cardiac fibroblasts and vascular smooth muscle cells29.   
Beyond E9.5, the heart continues to develop and remodel; this includes events such 
as trabeculation and compaction of the ventricular myocardium30, development of the 
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sinoatrial node which consists of pacemaker cells that regulate cardiac contraction31, 
remodeling and maturation of the endocardial cushions to form the cardiac valves32 and 
septation of the OFT, ventricles and atria33. Thus, during the early stages of heart 
development (~E7.5-E9.5), a myriad cardiac cell subtypes are specified from their 
respective progenitor domains to contribute to distinct structures of the heart as it 
undergoes major morphogenetic changes. This multi-chambered organ then serves as a 
scaffold for further refinement, growth and maturation.  
 
1.3 Patterning events during early cardiogenesis  
 
Cardiac specification and morphogenesis are regulated by molecular patterning 
events that confer morphological asymmetry as well as regionalization of gene expression 
and cell fate. Pitx2-mediated left-right (L/R) asymmetry in the cardiac crescent and 
anterior-posterior patterning of the SHF by retinoic acid signaling are two major patterning 
events that occur in cardiogenesis.  
The rightward looping of the heart at E8.5 is the first visible sign of asymmetric 
morphogenesis, but the molecular drivers that govern cardiac left-right identity are 
established much earlier. The most upstream signal that defines L/R identity at the 
cardiac crescent stage comes from the node, the signaling organizer of the gastrulating 
mouse embryo34. Cilia in the node exhibit left-sided rotational movement that causes a 
leftward movement of fluid, known as nodal flow35. This results in asymmetric expression 
and secretion of Nodal, a member of the TGF-ß family, in the left LPM. Through activation 
of its receptor complex (comprising its co-receptors, Cfc1, Acvr1b and Acvr2b) and 
subsequent downstream signaling, Nodal activates transcription of itself and its 
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antagonist Lefty2 and the downstream transcriptional effector of asymmetry, Pitx223,36,37. 
Lefty-2 establishes a negative feedback loop that limits Nodal signaling to a short time 
window of just a few hours. Additionally, expression of a second Nodal antagonist Lefty-
1 in the embryonic midline is induced by Shh signals38, to suppress Nodal expression in 
the right LPM. Once activated in the left LPM, asymmetric expression of Pitx2 persists in 
the left side of the cardiac crescent and the SHF; a day later its expression persists on 
the left side of the heart tube, including the left prospective sinoatrial, ventricular and 
outflow tract region39.  
Once activated, Pitx2 controls localized changes in cell migration, shape, extracellular 
matrix composition, regional proliferation and survival to drive asymmetric features of the 
developing heart40,41. It is important for the completion of heart looping (although its loss 
does not impact the direction of looping)23, for asymmetric proliferation in the sinus 
venosus, where it represses proliferation on the left side, and for driving OFT lengthening 
by promoting myocardial proliferation in the left OFT42. Additionally, rotation of the OFT, 
which is critical for proper positioning of the aorta and pulmonary artery, is Pitx2-
dependent43. Pitx2 is also required for maintenance of left atrial identity as its loss leads 
to right atrial isomerism, where both atria have a right-specific gene expression pattern 
and morphology44. This condition is the most commonly occurring laterality defect-based 
CHD45. However, little is known about the transcriptional targets of Pitx2 underlying 
establishment of L/R asymmetry. Moreover, the presence and identity of signals and 
transcriptional mediators that define right-sided identity have yet to be uncovered23.   
Patterning of the SHF into the transcriptionally distinct AHF and pSHF domains is 
regulated by retinoic acid signaling-mediated transcription of Hox genes, which are 
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important regulators of anterior-posterior patterning throughout the developing embryo46.  
Retinoic acid is a crucial developmental regulator that functions as a ligand for nuclear 
receptors, retinoic acid receptors (RAR) and retinoid X receptors (RXR), to control 
transcription of target genes47,48. It is a metabolite of vitamin A, which is first converted to 
retinaldehyde by alcohol dehydrogenases, followed by irreversible oxidation of 
retinaldehyde by retinaldehyde dehydrogenases to retinoic acid (RA). The retinaldehyde 
dehydrogenase family member Raldh2 is responsible for almost all RA production during 
early development48. At E7.5, Raldh2 expression occurs in the LPM just posterior to the 
cardiac crescent; RA generated by Raldh2 activity in this LPM domain diffuses into the 
posterior region of the SHF49 where it regulates transcription of target genes that define 
the pSHF domain and confer atrial identity50,51.  
In germline deleted Raldh2-/- mouse embryos, expression of the lacZ transgene driven 
by a retinoic acid response element (RARE-LacZ) and the retinoic acid target gene Hoxa1 
is completely abolished in the pSHF region50. Notably, expression of AHF markers 
including Fgf8, Fgf10 and Tbx1 is expanded posteriorly and the posterior expression of 
the pan-SHF marker, Isl1 is caudally extended. This expansion is a result of defects in 
establishing the posterior cell fate, and not due to abnormal posterior migration of AHF 
cells50. These data indicate that RA signaling is important for defining the anterior and 
posterior limits of the pSHF50,52. Phenotypically, Raldh2-/- mutants have disrupted atrial 
and sinus venosus development, consistent with the anteriorized pSHF signature50,53. 
Inhibition of RA-induced transcription during early cardiogenesis leads to defective hearts 
lacking the atrial chambers, consistent with RA being a driver of atrial cell fate through 
pSHF cell patterning51.  However, development of AHF structures is also disrupted upon 
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perturbing RA signaling; Raldh2-/- mutants have OFT defects, likely reflecting the 
contribution of multiple RA-dependent Hox gene-expressing pSHF subdomains to the 
distal part and inferior wall of the OFT54–56.  
The retinoic acid signaling axis intersects with the T-box transcription factors Tbx1 and 
Tbx5 in establishing the pSHF domain57. Tbx1 regulates the allocation of SHF progenitors 
to the arterial and venous poles56 whereas Tbx5 is a canonical pSHF marker gene critical 
for venous pole development16,58 that does not contribute to the arterial pole13. RA 
signaling activates Tbx5 expression in a subpopulation of Tbx1+ cells in the posterior SHF 
region at the heart tube stage; this results in Tbx5 rapidly downregulating Tbx1 expression 
and forming a transcriptional boundary between Tbx5+ venous pole cells and Tbx1+ 
arterial pole cells. Disruption of RA signaling and subsequent inhibition of Tbx5 activation 
in this boundary compartment leads to defects in atrial and ventricular septal structures56. 
In summary, RA signaling is critical in early cardiogenesis to appropriately pattern the 
pSHF and define the progenitor subcompartments that contribute to the arterial and 
venous pole structures of the heart which are common targets of CHDs.  
 
1.4 Cellular diversity in the developing heart 
 
The developing heart contains a tremendous diversity of cells6,16. Among the broad 
categories of cardiac cell types, such as cardiac progenitor cells (CPCs), myocytes, 
endothelial cells, smooth muscle cells and mesenchymal cells, each structure of the heart 
displays region-specific gene expression patterns for these cell types. For example, 
myocytes of the ventricles, atria, SV, AVC and OFT have distinct gene signatures, 
reflecting differences in electrophysiology, chamber vs non-chamber myocardium identity 
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and differential usage of isoforms encoding contractile genes59. In addition, these cell 
subtypes are generated through successive specification events from their respective 
progenitors via intermediate precursors60.  
During morphogenesis, these heterogeneous cell populations are dispersed 
throughout the developing heart. Given the exceedingly small size of mouse embryos and 
the developing cardiogenic region, physical separation of these cell types in order to 
interrogate their molecular signatures and function is challenging and relies on a priori 
knowledge of marker genes, which may introduce unintended bias that affects both the 
questions asked and the conclusions that are drawn. Use of bulk assays to measure 
cardiac cellular features such as gene expression have not been fruitful, due to the fact 
that these platforms measure data averaged through the entire population of cells. In light 
of these limitations, attempts to understand the molecular mechanisms underlying how 
CPCs are specified to multiple cell subtypes and to comprehensively catalog the extent 
of cellular heterogeneity of the developing heart, have been hampered. In recent years 
however, new assays that leverage microfluidic technology to capture and measure 
molecular features of large numbers of individual cells have gained traction.  Of these 
technologies, the most widely employed and mature modality is single-cell RNA 
sequencing (scRNA-seq), which has greatly improved our ability to access and study 








1.5 Leveraging single-cell transcriptomics to dissect cardiogenesis  
 
Without question, scRNA-seq is revolutionizing our ability to precisely dissect the 
behaviors, functions and interactions of individual cells in organogenesis, homeostasis 
and disease pathogenesis at genome scale. This has enabled the discovery of novel cell 
types, revisions to established lineage hierarchies and identification of novel cell fate 
determinants when applied to developmental contexts62–67. Single-cell transcriptomics is 
thus accelerating the pace, scale and resolution of biological discovery.   
Prior work that applied single-cell transcriptomics to study cardiogenesis between 
E7.5 and postnatal day (P)21, used plate-based platforms that allow capture of small 
numbers of cells (1200-2500 cells) with greater coverage and detection of genes59,68–70. 
These studies uncovered novel genes in broad cardiac cell types, described the 
differentiation and specification defects incurred in cardiomyocytes upon loss of CHD-
causing genes and identified heterogeneity and transcriptional features of early 
committed Mesp1+ cardiac progenitor cells. A recent study of ~400 single-cell 
transcriptomes captured from developing human hearts identified the LGR5 gene as a 
key regulator of progenitors that contribute to the cono-ventricular region71. These reports 
highlighted the value of applying scRNA-seq to quantitatively measure and understand 
heterogeneity in mouse and human cardiac development transcriptome-wide.  
 Droplet-based scRNA-seq technologies, where individual cells are co-
encapsulated with barcoded beads that capture and encode transcript information, allow 
acquisition of large numbers of transcriptomes72. These technologies can thus further 
advance our understanding of cardiogenesis, by enabling us to sample cell type 
heterogeneity more fully, identify rare cell populations and dissect how loss of cardiac 
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genes differentially impact distinct cell populations. CHDs arise from dysregulation of 
specific subsets of cell subpopulations. Thus, large-scale single-cell transcriptomics can 
be leveraged in settings where cardiac development is perturbed and leads to CHDs, to 
dissect which cell subsets are dysregulated, and precisely determine the functional 
consequences of that dysregulation. These settings include genetic loss of important core 
cardiogenic transcription factors.  For example, the Hand2 transcription factor is critical 
for development and morphogenesis of the SHF, but the mechanisms by which its loss 
disrupts SHF development are largely unknown. Thus, single-cell RNA sequencing 
represents a valuable opportunity to determine the consequences of Hand2 loss in early 
cardiac development.   
 
1.6 Hand2 functions in cardiogenesis.  
 
 The Hand2 gene encodes a basic helix-loop-helix (bHLH) transcription factor, that 
was discovered in a screen to identify bHLH transcription factors expressed during heart 
development. Hand2, then known as dHand due to its strong expression in the mouse 
deciduum, was found to be expressed in the mouse lateral plate mesoderm and cardiac 
crescent at E7.75, followed by expression throughout the heart tube and SHF at E8.25 
and abundant expression in the OFT and neural crest-derived aortic arch arteries, with 
lower expression in the developing ventricles and atria at E9.2573,74. Expression of Hand2 
was also found to be more enriched in the right ventricular chamber, compared to the left 
ventricle. The expression domain of Hand2 in these regions spanned both the 
myocardium and endocardium. Expression of the closely related family member Hand1, 
which has been shown to function redundantly with Hand273,75,76, was in regions of the 
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heart that overlapped with Hand2, such as the OFT, and was highly enriched in the outer 
curvature myocardium of the LV75,77.  
The compartment-specific expression pattern of Hand2 in these early stages of 
cardiogenesis suggested that it might be important for heart formation. Indeed, this was 
confirmed upon genetic deletion of Hand2 in mouse embryos, which resulted in 
embryonic lethality due to heart failure by E10.5. These Hand2-null mutant embryos 
exhibited a single left-sided ventricular chamber, a shortened OFT and markedly dilated 
aortic sac. The complete lack of a right ventricle was consistent with the predominant right 
ventricular expression of Hand2. These findings established Hand2 as a marker and 
essential regulator of right ventricular chamber formation, while Hand1 emerged as an 
essential marker and regulator of left ventricular formation75,78,79.  
Tissue-specific deletion of Hand2 revealed its critical functions in neural crest cell-
derived lineages, the developing limb and the heart11,80–85. Notably, Hand2 deletion in the 
entire SHF domain phenotypically recapitulated the defect incurred upon its global 
deletion, revealing its essential role in regulating the SHF11.  This study implicated Hand2 
as a driver of SHF cell survival, since its loss resulted in increased apoptosis of SHF 
progenitors in the pharyngeal mesoderm, prior to migration into the arterial pole of the 
heart. Moreover, temporal deletion of Hand2 in sub-lineages of the SHF revealed a 
spectrum of malformations reminiscent of human congenital heart defects. 
Over the past twenty years since the discovery of Hand2, much has been 
uncovered about its requirement in multiple tissue lineages, its impact on diverse cellular 
behaviors in the developing embryo as well as its function as a core cardiac transcription 
factor86,87. However, the transcriptional targets of Hand2, as well as a mechanistic 
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understanding of how it regulates the fate and behavior of distinct cardiac subpopulations 
have been challenging to uncover, particularly during early stages of cardiogenesis, 
where progenitor cell gene expression is dynamic and access to individual 
subpopulations is limited.  Thus, one of the major goals of my thesis was to leverage 
single-cell RNA sequencing to understand how Hand2 loss impacts early specification 
and behavior of SHF progenitors in the developing heart.  
 
1.7 Specific aims 
 
The advent of single-cell RNA sequencing technologies that enable the capture of 
large numbers of transcriptomes represents an invaluable opportunity to study 
cardiogenesis at high resolution. Accessing the cellular compartments that contribute to 
specific structures of the heart has thus far been intractable, particular with respect to rare 
cell populations. Moreover, dissecting how distinct cell types are dysregulated, 
interrogating the nature of that dysregulation and understanding how it impacts heart 
formation is now possible, with important implications for understanding the mechanisms 
underlying manifestation of CHDs in human patients.  
In this work, we leveraged droplet-based capture of single-cell transcriptomes to 
study normal and abnormal cardiac development in vivo during murine development. We 
focused our efforts on the enigmatic early stages of cardiogenesis, when cardiac cell 
subtypes are undergoing active specification from their respective progenitor 
compartments and the developing heart is undergoing major morphogenetic changes. 
Our goal was to categorize all the cell types and cell states that we captured in normal 
development and identify fate-determinants that drive specification of multiple cardiac 
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subtypes from the same progenitor domain. We then used this high-resolution molecular 
framework to dissect how loss of the lineage-specifying transcription factor, Hand2, 
disrupts these cell populations, resulting in a complex developmental defect. Collectively, 
this work presents a valuable resource for the cardiac development field, uncovers how 
loss of a broadly expressed transcription factor leads to differential perturbation in distinct 
cell types and demonstrates how single-cell RNA sequencing can be leveraged to reveal 











































The heart develops from diverse cell lineages that are specified from two pools of 
cardiac progenitor cells (CPCs), the FHF and SHF, and multipotent neural crest cells, yet 
our understanding of the molecular regulators that specify distinct fates from these 
domains is limited. While several decades of research in the cardiac development field 
have uncovered lineage-specific markers and important cell-fate regulators of these 
populations, an unbiased transcriptome-wide characterization of the cellular diversity of 
the heart has not been possible until now, due to limitations of bulk technologies. The first 
goal of my thesis was to use single-cell RNA sequencing to capture cardiac cell 
transcriptomes from wild-type (WT) mouse embryos, in order to comprehensively 
describe and interrogate the cellular heterogeneity of the developing heart.   
 
2.2 Mapping early cardiogenesis at single-cell resolution 
 To identify transcriptional features of cardiac cell fate specification and 
morphogenesis at the single-cell level, we used the 10X genomics Chromium platform72 
to capture transcriptomes of cells from the cardiogenic region in mouse embryos at three 
developmental stages: 1) as CPCs begin to differentiate and form a late cardiac crescent 
at  E7.75; 2) as the FHF forms a linear, beating heart tube and the SHF migrates into the 
anterior and posterior poles of the tube at E8.25; and 3) as the heart tube loops and 
incorporates the SHF-derived right ventricle and atrial cells with the FHF-derived left 





Figure 2.1: Capture of cardiac populations in early mouse embryos.  
a, Representative images of mouse embryos at E7.75, E8.25 and E9.25 used for cell 
collection, with micro-dissected regions indicated, in frontal view (top) and right sagittal 
view (bottom). Scale bar, 200 µm. b, Spatial organization of captured cardiac cell 
populations at each stage. Darker shaded region on left side of SHF at E7.75 indicates 
left-right asymmetric patterning. Dots in the SHF at E7.75 represent differentiating RV, 
OFT, atrial and SV cells as indicated by the color labels. HF, head folds; CC, cardiac 
crescent; HT heart tube; RV, right ventricle; LV, left ventricle; PA, pharyngeal arches; FHF, 
first heart field; SHF, second heart field; AHF, anterior heart field; pSHF, posterior second 
heart field; NC, neural crest cells; OFT, outflow tract; SV, sinus venosus; A, Atria; PEO, 
proepicardial organ containing epicardial cells.  
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We sequenced the transcriptomes of 36,777 cells, including ectoderm and 
endoderm progenitors that were unintentionally captured during dissection of the mouse 
cardiogenic region, over the three developmental time-points (Fig. 2.2a, b). We 
computationally excluded these ectoderm and endoderm cells as well as contaminating 
blood cells that were captured at E9.25 (Fig. 2.2c). We applied a graph-based clustering 
approach on the remaining 21,366 neural crest-derived mesenchyme cells and 
mesoderm populations. This analysis partitioned the cells into 7 broadly defined 
populations: multipotent Isl1+ progenitors, endothelial/endocardial cells 
(Cdh5+/Emcn+/Plvap+)88–90, epicardial cells (Tbx18+/Wt1+)91,92, myocardium 
(Myh7+/Myh7+/Tnnt2+), neural crest-derived mesenchyme cells (Dlx2+/Dlx5+)93,94, 
paraxial mesoderm (Tcf15+/Meox1+)95,96 and posterior lateral plate mesoderm 
(Hoxb6+/Foxf1+)97,98 (Fig. 2.2d, e). We subdivided the multipotent Isl1+ progenitors, 
endothelial/endocardial cells and myocardium populations to appreciate additional 
heterogeneity (Fig. 2.3). To assign identities to these subpopulations, we cross-
referenced the most highly and uniquely expressed genes in each subpopulation with 
known cardiac subtype markers and in situ hybridization data from the literature 
(Supplementary Table 2.1). We further validated several of these marker genes by 
fluorescence in situ hybridization, which provided spatial resolution (Fig. 2.4). 
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Figure 2.2: Single-cell RNA-seq reveals heterogeneity of cardiac populations. 
a, UMAP plot of all captured cell populations colored by cluster and b, stage of collection. 
c, UMAP plot showing expression of markers used to identify contaminating populations. 
d, UMAP plot of mesodermal and neural crest populations colored by cluster identity and 
embryonic stage of collection. e, Expression heatmap of marker genes of populations. 
Statistics for differential gene expression tests were applied to n = 21, 366 cells. Data are 
shown for 100 cells subsampled from each population. Scale indicates Z-scored 
expression values. MP, multipotent progenitors; EC, endocardial or endothelial cells; PM, 
paraxial mesoderm; LPM, lateral plate mesoderm. 
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Figure 2.3: Focused analyses of cardiac populations.  
Schema of progressive subdivisions of broadly clustered cell populations from Fig 2.2d.  
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Figure 2.4 legend continued on next page 
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Figure 2.4: Spatial validation of marker gene expression by in situ hybridization.  
a, Ventral view of Tdgf1 and Tnnt2 expression in the CC, right lateral views of Wnt5a and 
Bmp4 in the OFT, Mab21l2 and Shox2 in the SV, and Hoxa1 and Hoxb1 in the posterior 
pSHF by in situ hybridization at days indicated that informed assignment of population 
identities. b, Expression of Tbx1 in the SHF and pharyngeal arches PA and novel 
unannotated gene 3632451O06Rik in the OFT at E8.25 and E9.25. c, Expression of Rgs5 
and Isl1 in the SHF, Hand2 in the SHF and OFT and Tbx18 in the PEO of E9.25 embryos. 
Scale bars indicate 200 µm unless otherwise noted. d, In situ hybridization of mRNA 
expression of Isl1, Fgf8 and Hoxb1 at E8.25 and Nr2f2 at E9.25 in right lateral histologic 
sections. n=2 independent embryos per gene for all panels. Scale bars indicate 50 µm. 
H, head. 
 
Within each broad population of cells, further sub-clustering revealed distinct cell 
types characteristic of unique progenitor pools that are spatially organized 
(Supplementary Table 2.1). Among the endocardial/endothelial lineage, we captured 
three subpopulations of the endocardial/endothelial lineage: hematoendothelial 
progenitors (Etv2high/ Tal1high/ Cdh5low)99, specified endothelial/endocardial cells 
(Cdh5high/Pecam1+/Emcnhigh), and endocardial cells initiating an endothelial-to-
mesenchymal transition program typical of valve development 
(Hand2high/Msx1high/Gata4high)22 (Fig. 2.5 a, b). The Isl1+ multipotent progenitor population 
subdivided into the AHF, pSHF, and branchiomeric muscle progenitors that reportedly 
share a common origin with SHF cells (Fig. 2.5c, d)100,101.  
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Figure 2.5: Heterogeneity in endocardial or endothelial cells and multipotent 
progenitor populations.  
a, UMAP plot of reclustered endocardial or endothelial population colored by cluster and 
embryonic stage of collection. b, Violin plot of markers indicating distinct subpopulations 
of endocardial or endothelial cells. Summary statistics reported in all violin plots: the 
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center white line represents median gene expression and the central black rectangle 
spans the first quartile to the third quartile of the data distribution. The whiskers above or 
below the box indicate value at 1.5x interquartile range above the third quartile or below 
the first quartile. Statistics for differential gene expression tests were applied to n=2,199 
cells.  c, UMAP plot of reclustered multipotent progenitor populations colored by cluster 
and embryonic stage of collection. d, Heatmap showing curated list of marker genes that 
identify pSHF, AHF and branchiomeric muscle progenitors. Scale indicates Z-scored 
expression values. Statistics for differential gene expression tests were applied to 
n=5,376 cells.  HE, hemato- endothelial progenitors; EC, endocardial or endothelial cells; 
EndMT, endothelial-mesenchymal transition cells; AHF, anterior heart field; pSHF, 
posterior second heart field. 
 
We also identified transcriptomes representative of ventricular (Irx4+)102,103, atrial 
(Cav1+/Kcna5+)104,105, sinus venosus (Shox2+)106, atrioventricular canal (AVC, 
Rspo3+/Bmp2+)107,108 and OFT Tdgf1high/Rspo3+/Irx4-)107,109 myocardium (Fig. 2.6a, b). 
We defined the gene signatures of each of these sub-populations as these transcriptomes 
provide the first insight into the broader genes expressed in specific cell types of the heart. 
For example, a novel, unannotated single-pass transmembrane domain protein, 
3632451O06Rik, emerged as highly enriched in OFT myocardium (Fig. 2.6b). Although 
the human ortholog of 3632451O06Rik has been shown to interact with mTORC2110, the 
putative cardiac function of this gene and its role in OFT cells has not been interrogated. 
We also found highly enriched expression of the Regulator of G protein signaling gene, 
Rgs5, in the second heart field and OFT (Fig. 2.4c). Signaling mediated by G-proteins is 
critical for development of the heart, particularly for SHF-derived structures111–114, and 
Rgs5 may be involved in regulating these pathways. This dataset therefore represents a 
catalog of cardiac cell states that arise during embryonic development, along with their 
transcriptomes, providing a foundation to study the transcriptional dynamics underlying 
specification of cardiac subtypes, as well as to uncover novel cell type specific genes.  
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Figure 2.6 legend continued on next page 
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Figure 2.6: Focused analyses of myocardial populations and spatial validation of 
right ventricle markers.  
a, UMAP plot of reclustered “Myocardium” population colored by cluster and embryonic 
stage of collection. b, Heatmap of highly and uniquely expressed genes in myocardial 
subpopulations. Scale indicates Z-scored expression values. Statistics for differential 
gene expression tests were applied to n=6,474 cells. c, UMAP plot of reclustered 
ventricle populations colored by cluster and embryonic stage of collection. d, Heatmap 
showing curated list of genes that identify left ventricle (LV), right ventricle (RV) and early 
RV progenitors. Scale indicates Z-scored expression values. Statistics for differential 
gene expression tests were applied to n=1,976 cells.  e, mRNA expression of left 
ventricle marker Hand1 (green) and Pln (red) in frontal view of the E9.5 heart showing 
enrichment in right ventricle region by whole mount in situ hybridization. n=2 
independent embryos per gene, Scale bar, 200 µm. f, Breeding scheme for lineage-
tracing Cck expressing cells. g, mRNA expression of endogenous Cck and TdTomato 
driven by Cck-cre transgene at E9.25 in right oblique view of the heart. n=2 independent 
embryos per gene; scale bar, 200 µm. h, Expression of TdTomato in whole-mount and 
sectioned postnatal day 1 (P1) heart from Ai14xCck-cre lineage-traced mice showing 
location of progeny of Cck-expressing cells. Left panels show brightfield view (top) or 
TdTomato (bottom) of whole-mount P1 heart; right panels show sections of TdTomato 
and DAPI (top) or TdTomato alone (bottom) in postnatal day 1 (P1) heart section. n=2 
independent embryos.  Scale bar, 100 µm.  EMP, early myocardial progenitors; AVC, 
atrioventricular canal; IVS, interventricular septum. 
 
While the left and right ventricles perform similar functions, they arise from distinct 
progenitors. Moreover, dysregulation of genes that are uniquely enriched in either of 
these populations leads to chamber-specific congenital malformations74,115. In order to 
identify novel genes characteristic of the LV and RV, we subdivided the ventricle (V) 
population (Fig. 2.6a) comprising 1,976 cells to three populations, one of which 
represented the LV based on its highly enriched expression of the genes Hand1 and 
Cited1 (Fig. 2.6c, d)116. The remaining two Hand1-/Cited1- populations are RV, where 
one represents a less differentiated population (termed Early RV progenitors) due to its 
lower expression of ventricular myocardium genes such as Myl2, Tnni3 and Nppa and 
the higher expression of AHF progenitor genes such as Fgf8117 (Fig. 3.6d). Several genes 
were enriched in only one chamber, consistent with their distinct origins and physiology 
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(Supplementary Table 2.1). Surprisingly, Phospholamban (Pln), a critical regulator of 
calcium handling118, and the Cholecystokinin gene (Cck), encoding an intestinal and 
neuronal peptide hormone119, were predominantly expressed in RV cells (Fig. 2.6d, e). 
In situ hybridization confirmed the RV dominance of Cck and also revealed enrichment in 
the region of the future ventricular septum at E9.25 (Fig. 2.6f, g). Lineage tracing of Cck 
expressing cells and their progeny using a constitutive Cck-IRES-Cre transgenic mouse 
crossed with a floxed TdTomato reporter mouse further established their enrichment in 
the RV, particularly the trabecular myocardium, and the IVS, with some expression in 
parts of the atria (Fig. 2.6g, h). These data demonstrate the power of leveraging single-
cell transcriptomics to reveal unique genes that characterize diversity among highly 
similar cell subtypes with distinct physiologies.  
A myocardium population that we could not ascribe to a known cell type comprised 
a large proportion of E7.75 cells and expressed genes of multiple myocardium subtypes 
such as Irx4 (ventricle) and Angpt (atrial)120 (Fig. 2.6a, b). We hypothesized that these 
cells represent a mixed population of early myocardium progenitors (EMP) including FHF 
cells. To test this hypothesis, we used pseudotemporal ordering, which is a computational 
measure of the progress a cell makes along a differentiation trajectory121.  We constructed 
a trajectory of all the myocardium populations described above, which revealed 6 major 
cell states (Fig. 2.7a-e). The majority of cells from the EMP population were placed at the 
start of the trajectory along with a subset of cells classified as SV, suggesting that the two 
populations were in a transcriptionally similar cell state, while the remaining SV cells were 
placed with atrial and AVC cells along the trajectory, consistent with their overlapping 
gene expression signatures (Fig. 2.6b). Notably, EMP cells from the later time points 
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were represented in all other myocardial cell states, consistent with our hypothesis (Fig. 
2.7b). Additionally, the early RV progenitor cells identified in the ventricle analysis were 
placed with the OFT state (State 4), a state comprising differentiated LV/RV cells (State 
6) and an intermediate state (State 5) that expressed lower levels of differentiated 
ventricle genes, such as Nppa122 and higher levels of Fgf8, supporting their broad 
designation as early RV progenitors (Fig. 2.7d, f). We used the pseudotime analysis to 
identify several genes that are dynamically expressed and enriched in the EMP/SV and 
OFT states such as Abra, Dlk1, Cfc1, Ifitm1, Mtus2, Marcks and Phlda2 (Fig. 2.7g). This 
analysis also identified the Hand2 gene, which is typically considered a marker of 
ventricular identity77 to be more highly expressed in outflow tract myocardium cells than 
ventricle cells. In situ expression analysis at E9.25 also confirmed the enriched 
expression of Hand2 in the OFT (Fig. 2.4c).  
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Fig. 2.7 legend continued on next page 
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Figure 2.7: Pseudotemporal ordering of myocardium populations.  
Pseudotime trajectory of myocardium populations colored by a, pseudotime value, b, 
cluster identity, c, embryonic stage of collection and d, cell state. Pseudotime trajectory 
analysis was applied to n=6,474 cells.   e, Percentage of cells in each state that were 
captured at E7.75, E8.25 or E9.25. f, Violin plots showing expression of Nppa and Fgf8 
in State 5 and State 6 from pseudotime trajectory in (d). g, Expression dynamics of select 
genes along the myocardium pseudotime trajectory. Dots represent individual cells at 
indicated relative expression levels colored by cluster identity. Statistics for differential 
gene expression tests were applied to n = 455 cells from each state. Bonferroni correction 
adjusted p-value < 1x10-4 (Wilcoxon rank sum test, two-sided).  
 
2.3 A framework to investigate gene function in distinct cell types 
CHDs are caused by disruption of relatively small subpopulations of cardiac cells 
during development and substantial efforts are ongoing to identify genetic variants that 
underlie the large majority of CHD cases5. Many novel genes previously not implicated in 
heart development have been identified from these studies, but the cell types in which 
they function are unknown. A high-resolution molecular framework of cardiogenesis such 
as the one presented here can be leveraged to link the expression of such novel genes 
to specific cell types. To that end, we cross referenced the marker genes identified in all 
captured populations in our dataset against genes identified in CHD patients with 
damaging de novo mutations as assessed by the MetaSVM algorithm5 and identified 
several that demonstrated cell type specific or enriched expression patterns. These 
included Upp1 and Flt4 in the endocardium/endothelium and Prkaa2, Rrad and Ank3 in 
the myocardium (Fig. 2.8). Thus, our single cell dataset represents a valuable resource 
to identify cell populations that may be dysregulated and contribute to CHD pathogenesis.  
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Figure 2.8: Novel genes associated with CHD are enriched in specific cardiac 
populations.  
UMAP plot of all mesodermal and neural crest populations captured at E7.75, E8.25 and 
E9.25 colored by cluster identity and showing expression of Flt4 and Upp1 in endocardial 
or endothelial population and Rrad, Ank3 and Prkaa2 in sub-populations of the Myocardium.  
 
2.4 Dissecting additional heterogeneity of cardiac progenitor cells  
Previous studies employing clonal genetic fate mapping and scRNAseq of the 
earliest Mesp1+ cells demonstrated that these cells are specified towards committed 
CPCs fated for distinct anatomic regions and lineages between E6.25 and E7.513,14,69.  
Given that our dataset contained large numbers of CPCs, compared to previous single-
cell CPC analyses59,68,69, we sought to characterize the additional heterogeneity within 
this compartment. We focused on the AHF and pSHF populations captured at E7.75 and 
E8.25 (Fig. 2.5c), and this analysis further subdivided the CPCs into nine populations 
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(Fig. 2.9a, Supplementary Table 2.1). Populations A–C were of pSHF origin, whereas 
E–I were of AHF origin.  The pSHF cluster A  and AHF cluster I were derived from E7.75 
and >50% of cells in each population co-expressed the left sided genes Nodal, Lefty2 and 
Pitx2,37 (Fig. 2.9a, b) suggesting that these populations contained left-right 
asymmetrically patterned progenitor cells. A differential gene expression test between 
Pitx2-positive (normalized UMI > 0.1) and Pitx2-negative (normalized UMI < 0.1) cells in 
A and I identified genes with putative asymmetric expression associated with these left-
right asymmetric markers (Supplementary Table 2.1). Population D, largely from E7.75, 
had enriched expression of LV genes such as Hand1, Mab21l2 and Irx475,103,123, along 
with sarcomeric genes, and minimal levels of Isl1, which indicates these cells are early 
FHF progenitors (Fig. 2.9b). Several populations of the AHF and pSHF lineages 
expressed genes indicative of myocardial differentiation (Tnnt2, Actc1, Myh7) prompting 
us to perform pseudotime analysis to gain insights into the distinct differentiation 
dynamics of the AHF and pSHF (Fig. 2.9c, d, e). The resulting trajectory suggests that 
pSHF clusters A and B might represent sequential stages of a differentiating population, 
while pSHF cluster C encompasses a continuum of cells that are differentiating to 
myocardium (Fig. 2.9b, d). Moreover, the AHF population F appears to represent the 
earliest outflow tract cells due to its expression of genes such as Hand177, Bmp4 (Fig. 
2.4a) and Dlk1 (Fig. 2.7g). This analysis identified the gene Upp1, which was previously 
unknown to function in the heart, enriched in differentiating pSHF myocardium. 
Additionally, the retinoic acid (RA) binding protein Crabp1, which inhibits RA signaling, 
was highly enriched in the differentiating AHF cells (Fig. 2.9b)124.   
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Figure 2.9: Analysis of cardiac progenitor cell populations reveals early 
specification dynamics of myocardial subtypes.  
a, UMAP plot of AHF and pSHF subclusters colored by cluster identity and embryonic 
stage of collection. b, Expression of indicated highly and uniquely expressed genes in 
subpopulations from (a). Scale indicates Z-scored expression values. Pseudotime 
trajectory of CPCs colored by c, embryonic stage of collection, d, population identity and 




2.5 Diversity of endodermal populations associated with cardiogenic mesoderm  
As CPCs form the cardiac crescent, induction of cardiac gene expression is driven 
by FGF and BMP signals secreted from the adjacent anterior endoderm125. We 
hypothesized that there may be other endodermal secreted factors expressed by the 
FGF- and BMP- secreting cells. To test this, we analyzed 915 Sox17+/Foxa2+ endoderm 
cells captured at E7.75 and identified five subpopulations (Fig. 2.10a, Supplementary 
Table 2.1. Expression of cardiac inducers Bmp2, Bmp4 or Fgf8 was enriched in specific 
subpopulations, suggesting that cardiac crescent cells receive combinatorial inductive 
signals from distinct endodermal cell subpopulations (Fig. 2.10b). Cluster 5 was highly 
enriched in genes characteristic of mesendoderm (Bry, Nog126 and Shh127)  while Cluster 
1 appears to represent the cardiogenic anterior visceral endoderm, expressing genes 
such as the Wnt antagonist Dkk1 and factors such as Otx2 and Gsc128 (Fig. 2.10c), 
revealing the previously undescribed transcriptomes of this, and other, specific 
endodermal populations. For example, we identified Wnt5a, a non-canonical Wnt ligand, 
enriched in multiple clusters that co-expressed Bmp4, Bmp2 and Fgf8 (Fig. 2.10b). While 
Wnt5a is expressed and required in the SHF129, its expression in the endoderm at E7.75 
was unappreciated, as broader transcriptomes of cardiogenic endoderm were not 








Figure 2.10: Endoderm populations adjacent to the cardiac crescent.  
a, UMAP plot of endoderm populations captured at E7.75. b, DotPlot of expression 
patterns of known and novel endodermal secreted factors. The size of the dot indicates 
the percentage of cells expressing that gene within a cluster, while the color encodes the 
average expression level of that gene within a cluster. c, Expression heatmap of the top 
ten marker genes of each endodermal population. Scale indicates Z-scored expression 
values. Statistics for differential gene expression tests were applied to n = 915 cells.    
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2.6 Predicting cell fate determinants of AHF derivatives   
The AHF gives rise to chamber (RV) and non-chamber (OFT) myocardial lineages. 
However, the molecular regulators governing differential specification of these lineages 
are unknown. To identify such lineage specifiers using our single-cell RNA sequencing 
data, we applied a Boolean network-based computational method that takes as input a 
list of differentially expressed genes between a parent progenitor cell population and the 
two daughter cell populations representing different fates to systematically predict cell-
fate determinants130,131  (see Methods and Supplementary Table 2.1). The procedure was 
applied to E7.75 and E8.25 AHF, RV and OFT cells and identified Irx4 and Plagl1 as 
lineage specifiers of the RV, while Hand2, Tead2 and Arid3b were determined as 
specifiers of the OFT. Irx4 is an established specifier of ventricular identity102,103, thus its 
identification as a cell fate determinant for RV cells confirms the validity of this analysis. 
Arid3b is important for the deployment of SHF progenitors132 and its deletion results in 
OFT shortening, supporting its identification as a determinant of OFT fate. The prediction 
of Hand2 as a specifier of OFT cells from our lineage-determinant analysis is consistent 
with its differential, enriched expression in the OFT myocardium population (Fig. 2.5b). 
However, it was surprising that Hand2 was predicted as a lineage specifier for the OFT, 
but not RV, myocardium as its global deletion causes lethality by E10.5 secondary to 
severe RV hypoplasia74. This phenotype is recapitulated upon conditional deletion of 
Hand2 in the SHF, underscoring the requirement of Hand2 in this progenitor 
compartment11. How RV hypoplasia occurs in this genetic model is unknown, in part due 
to a previous inability to access individual progenitor cells that may be disrupted during 
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specification. We address this gap in knowledge using single-cell RNA sequencing in 
Chapter 3.  
 
2.7 Conclusions and Discussion 
 In this work, we compiled a high-resolution map of the cellular heterogeneity in 
early cardiogenesis. We identified novel cell-type enriched genes, described previously 
unrecognized heterogeneity in cardiac progenitor compartments, and uncovered lineage-
specifying regulators of the RV and OFT myocardium from the AHF. This endeavor 
represents the largest comprehensive catalog of cell subtypes in the developing heart 
and will be a valuable resource to the cardiac development community. Accordingly, we 
have partnered with Dr. Maximilian Haeussler and Dr. Matthew Speir to upload and format 
all processed datasets described herein on the UCSC cell browser at https://mouse-
cardiac.cells.ucsc.edu. The browser is a novice-user-friendly platform for wide 
dissemination and interrogation of gene expression in all cell types described in each 
analysis; users can also download the processed datasets for custom analysis. We 
envision that this resource will enable our community to develop and test novel 
hypotheses, glean more insights about cardiac development by applying innovative 
computational algorithms and advance our understanding of how the early events of 
cardiogenesis are orchestrated.  
 The extant cardiac development literature focused on cardiac lineage 
determinants and cell-type-specific marker genes was invaluable for defining the 
identities of the cell clusters revealed by our unbiased clustering approach. This exercise, 
which was critical for downstream analysis and interpretation of the data, was relatively 
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straightforward and is a testament to the vast and rigorous body of knowledge that has 
been compiled by the field. Given that we were able to identify all previously classified 
cardiac cell populations that we would expect to be present at these embryonic time 
points, we believe that our dissociation protocol did not bias us against capturing any 
known cardiac cell types. We however cannot eliminate the possibility that small 
populations were missed due to technical issues, such as dissociation bias or limited RNA 
capture inherent to the 10X Genomics platform, which precludes their identification during 
the analysis. It may also be the case that rare but distinct cardiac progenitor and 
differentiated populations were missed due to our computational analysis strategy. 
Application of rare cell type detecting analysis pipelines such as Giniclust133 and FiRE134 
may reveal the subtle transcriptional signatures of these proportionally minor, but likely 
functionally important, cell subsets.  
The AHF and pSHF progenitor domains comprise multipotent cell subsets that give 
rise to myocardial, endocardial and smooth muscle lineages of distinct regional 
compartments of the heart11,46. The additional heterogeneity revealed in our CPC 
reclustering analysis may represent these distinct sublineages. Moreover, these clusters 
may correspond to distinct medial-lateral or anterior-posterior positions within the AHF 
and pSHF. We attempted to gain further insights into this latter question using 
fluorescence in situ hybridization. These efforts were not fruitful due to the technical 
limitations of several mRNA probes not yielding signal. Sequencing-based modalities that 
capture both spatial and transcriptional information at high resolution135–137 are rapidly 
becoming widely employed, and are more suited to address this question.  We also 
identified heterogeneity in the endoderm overlaying the cardiac mesoderm at E7.75. It is 
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intriguing to consider whether the spatial positioning of endoderm subpopulations relative 
to the adjacent cardiac mesoderm determines specification of specific cardiac subtypes; 
this hypothesis can also be readily tested with spatial transcriptomics.   
Our comparison of LV and RV myocardium gene signatures revealed that very few 
transcriptional features can distinguish between the two cell types. This is underscored 
by the emergence of a single ventricle cluster in our myocardium analysis and the need 
to recluster this population in isolation to reveal the true ventricular cell heterogeneity. 
This reclustering analysis yielded a distinct third population that appeared to be less 
differentiated early RV myocardial cells; the presence of this precursor population for the 
RV but not LV cells likely reflects the delayed differentiation kinetics of SHF progenitors 
compared to FHF progenitors28. We identified strong enrichment of Cck in the RV and 
IVS, but not LV cells. It is unclear what role Cck plays during cardiogenesis in these cell 
compartments as Cck knock-out mice are viable and fertile138. We did not detect any 
expression of the Cck receptor genes, Cckar and Cckbr, in the captured mesoderm 
populations (data not shown). A study of Cck processing in adult pig hearts determined 
that cardiac pro-Cck is post-translationally modified to a unique, triple-sulfated and N-
terminally truncated product that is not present in Cck peptides of the intestine and 
nervous system139. This uniquely processed Pro-Cck cannot bind its canonical receptors; 
thus, it is possible that this Pro-Cck form is also expressed in cardiogenesis and its 
function relies on other receptors that remain to be uncovered.  
 The enrichment of Cck in the RV and IVS cells can be utilized as a tool to further 
probe the biology and developmental regulation of these cell types. For example, we 
could leverage high-resolution live imaging technologies such as light sheet microscopy 
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to visually map and characterize the behavior of Cck+ lineages labelled by constitutive or 
spatiotemporally controlled Cck-cre expression. These endeavors will shed light on the 
cellular dynamics of RV and IVS morphogenesis. Furthermore, in the next chapter, we 
demonstrate the utility of Cck expression as a marker that distinguishes RV from LV 
myocardium for dissecting the Hand2-null developmental phenotype.  
Taken together, this work presents a key resource of cardiac single-cell 
transcriptomes and an opportunity for broadening and refining our understanding of the 
critical early stages of heart formation. This foundation will be built upon in combination 
with innovative emerging single-cell technologies that measure complementary molecular 







































Hand2 is a bHLH transcription factor that is broadly expressed in multiple cardiac 
lineages, including the SHF-derived myocardium, endocardium and cardiac neural crest-
derived mesenchyme77. Global loss of Hand2 results in embryonic lethality by E10.5 due 
to a severely hypoplastic right ventricle and a shortened outflow tract11. The molecular 
mechanisms by which Hand2 loss leads to dysregulation of the SHF, particularly RV and 
OFT progenitors, are unclear. Thus, the second goal of my thesis was to dissect how 
global Hand2 deletion causes dysregulation in distinct sublineages of the SHF and leads 
to a heart defect. Additionally, our lineage-specifier analysis of single-cell transcriptome 
data from normal cardiogenesis identified Hand2 as a determinant of the OFT 
myocardium fate from the AHF. To resolve the discrepancy of the predicted lineage-
specifying function of Hand2 in the OFT, but not RV, and the morphologic loss-of-function 
consequence, we investigated the effects of Hand2 deletion on the fate and behavior of 
AHF progenitors using single-cell analyses. 
 
3.2 Transcriptional perturbation of Hand2-null cardiac populations 
We captured single-cell transcriptomes from Hand2-null embryos at E7.75, E8.25 
and E9.25 and compared these data to somite-matched WT controls. Given that the 
Hand2-null mutants and WT embryos are morphologically indistinguishable at E7.75 and 
E8.25, while the mutant hearts are clearly malformed at E9.25, we processed the 
transcriptomes of WT and Hand2-null cardiac cells captured at the two earlier stages 
together, and analyzed the E9.25 transcriptomes independently (Fig. 3.1; Table 3.1; 
Supplementary Table 3.1).  
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Figure 3.1: Capture of cardiac transcriptomes from Hand2-null embryos.  
a, UMAP plot of WT and Hand2-null cells colored by cluster, genotype and embryonic 
stage. b, Heatmap of marker genes of populations from a. c, UMAP plot of cardiac 
populations captured at E9.25 colored by cluster and genotype. d, Curated list of marker 
genes in cardiac populations at E9.25. Scale indicates Z-scored expression values.  
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We used the same analysis pipeline that was employed for clustering the 
transcriptomes from WT embryos with one notable difference: when regressing out 
sources of technical variability that could affect clustering, we also included the Hand2 
gene as a potential confounding variable. This analysis method resulted in clusters that 
comprised both WT and Hand2-null cells (Fig. 3.1). We performed differential gene 
expression analysis between WT and mutant cells of each population and found that the 
AHF, OFT and RV precursors were transcriptionally dysregulated as early as E7.75, well 
before visible manifestation of the cardiac defect (Fig. 3.2a-m; Supplementary Table 
3.1). For example, the Rgs5 gene, which we identified as a marker of the SHF and OFT 
from our WT analysis, was downregulated in Hand2-null AHF and OFT cells at E7.75 with 
exacerbated dysregulation at E8.25 (Fig. 3.2a, c, I, m). The chromatin remodeling gene 
Smyd1 was downregulated in Hand2-null AHF cells at E8.25, consistent with the 
observation that Smyd1-null mutants also display a hypoplastic right ventricle (Fig. 
3.2f)140. Smyd1 has been shown to regulate Hand2 expression, and our data suggests a 
positive feedback regulatory mechanism between these two genes. Other cardiac genes 
that were dysregulated in the AHF upon Hand2 loss included Cfc1, Lefty2, Bves, Popdc2 
and Nebl141–144. 
The retinoic acid binding protein-encoding genes, Crabp1 and Crabp2 emerged as 
highly dysregulated in the AHF, OFT and RV of Hand2-null mutants at E7.75 (Fig. 3.2a-
c). These genes are known to be opposing regulators of RA signaling, which defines and 
patterns the posterior second heart field progenitor compartment. Crabp1 binds and 
sequesters RA in the cytoplasm for degradation by RA catabolizing enzymes, while 
Crabp2 binds it and promotes its nuclear import to facilitate RA-mediated transcriptional 
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activation124,145. In Hand2-null AHF cells at E7.75, Crabp1 was downregulated while 
Crabp2 was upregulated, leading us to hypothesize that RA signaling is ectopically 
activated in the Hand2-null AHF. To test this hypothesis, we generated mice 
heterozygous for the Hand2-null allele and a LacZ reporter transgene under the control 
of a retinoic acid response element (RARE-LacZ). We intercrossed these mice and 
examined the distribution of LacZ expression in the resulting embryos by in situ 
hybridization. Remarkably, the LacZ reporter was ectopically expressed in the AHF 
progenitors extended into the cardiac outflow tract region in the Hand2-null mutants, while 
being restricted to the pSHF progenitor domain in WT embryos, as expected (Fig. 3.2j, 
m). We also observed upregulation of Hoxa1 and Hoxb1, which are established RA 
transcriptional targets and pSHF markers55, in the AHF at E8.25 and E9.25 (Fig. 3.2h, k, 
m), as well as the pSHF gene Osr1 at E7.75 (Supplementary Table 3.1) lending further 
support for our hypothesis of AHF posteriorization. Moreover, the gene Upp1, which is 
typically expressed in the posterior second heart field derivatives, such as the atria, was 
ectopically expressed in Hand2-null OFT and RV cells, indicating that these populations 
were also posteriorized (Fig. 3.2a, b, d, e, l, m). This suggests that while the AHF is 
mispatterned in Hand2-null embryos, transcriptional features of this abnormal identity are 
also conferred to the daughter cell types that differentiate from it.  Overall, these 
observations suggest that in Hand2-null mutant hearts, the initial SHF lineage 
commitment to the AHF and pSHF occurs, but AHF and AHF-derived cells exhibit 
aberrant transcriptional features of the pSHF and its derivatives.  
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Figure 3.2 legend continued on next page 
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Figure 3.2: Transcriptional perturbation of Hand2-null cell populations.  
a, Heatmap of differentially expressed genes between WT and Hand2-null OFT and b, 
RV cells captured at E7.75 and E8.25. Scale indicates Z-scored expression values. c-h, 
Violin plots showing dysregulated gene expression in the indicated cell compartments at 
indicated stages. i-l, mRNA in situ hybridization for expression of Rgs5 and Tbx5 at E8.25 
(i), RARE-lacZ transgene (j) and Hoxb1 (k) at E9.25, and Tdgf1 and Upp1 at E8.25 (l). 
m, Quantification of fluorescence signal for indicated genes in i-l. n=3 independent 
embryos per genotype. The mean +/- s.e.m is indicated. 
 
In addition to the posteriorized and delayed progenitor gene signature, the AHF 
and its derivatives displayed broader dysregulation. The gene Sema3c was ectopically 
expressed in the Hand2-null AHF at E8.25, and OFT and RV progenitors as early as 
E7.75 (Fig. 3.2a, d-f) Sema3c is an indicator of OFT cell differentiation and function, and 
is typically expressed later in the OFT myocardium to attract PlexinA2-positive neural 
crest cells at E8.5-E9.0 for OFT morphogenesis and septation24. This suggests that the 
regulatory mechanisms that prevent premature Sema3c expression in the AHF and its 
derivatives are abrogated upon Hand2 loss. The gene Tdgf1, which is highly restricted to 
the OFT at E8.25, was downregulated in Hand2-null OFT cells at E7.75 and almost 
absent in the OFT at E8.25 (Fig. 3.2a, e, l, m). Notably, WT and Hand2-null RV cells had 
equivalent expression of Irx4 at E7.75, suggesting that Hand2 loss did not prevent 
acquisition of a ventricular identity (Fig. 3.2d). However, Nppa, a known Hand2-target 
gene146, and Nppb, two markers of differentiation towards working myocardium were 
downregulated in Hand2-null RV cells at E8.25, indicating that these cells were 
dysregulated after specification (Fig. 3.2g).    
In order to determine whether the posteriorization of Hand2-null AHF progenitors 
resulted in additional defects related to AHF cell proliferation or differentiation, we 
calculated the proportion of WT and Hand2-null cells in each population that were 
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captured at E7.75. This analysis revealed that AHF cell numbers were not decreased in 
Hand2-null embryos (n=5), but rather both AHF and pSHF cell numbers were higher in 
the mutants than in WT embryos (n=3) (Fig. 3.3a). This increase in Hand2-null AHF and 
pSHF cells did not appear to be due to differences in proliferation because for each 
population, relatively equivalent numbers of cells in each cell cycle stage were captured 
from WT and Hand2-null embryos (Fig. 3.3b). However, at E9.25, WT AHF cells were 
efficiently activating genes involved with cardiac muscle contraction and sarcomere 
organization, such as Tnnt2 and Actc1, indicating that these cells were differentiating to 
myocardium. In contrast, Hand2-null AHF cells retained high expression of progenitor 
genes such as Tbx1147 and Fgf8117, which are typically downregulated as the AHF 
differentiates to its OFT and RV derivatives (Fig. 3.3c). Similarly, the Hand2-null pSHF 
compartment exhibited defects in differentiation at E8.25 (Fig. 3.3d). These data 
suggested that Hand2-null AHF and pSHF cells remained in a progenitor state unlike their 
WT counterparts which continued to differentiate.  
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Figure 3.3: Hand2-null SHF cells exhibit differentiation defects.  
a, Proportion of WT and Hand2-null cells from each population captured at E7.75. b, 
Proportion of WT and Hand2-null AHF and pSHF cells in each cell cycle stage at E7.75. 
c, d, Differentially expressed genes indicating a differentiation defect in the AHF (c) and 
















Hand1 is partially redundant with Hand2 in several contexts including the LV77, 
which is consistent with the intact LV in Hand2-null embryos at E9.25. We found that 
Hand1 is upregulated in the Hand2-null LV progenitors at E7.75 (Supplementary Table 
3.1); it is possible that this upregulation is a compensatory mechanism in response to 
Hand2 loss. Hand1 is also co-expressed in OFT progenitors at E9.25 but fails to 
compensate for Hand2 loss in this cell type. Intriguingly, we found that Hand1 was 
selectively downregulated in Hand2-null OFT, but not LV, progenitors, suggesting that the 
regulation of Hand1 expression in the LV and OFT are differentially dependent upon 
Hand2 function (Fig. 3.4a, b). Thus, Hand2-null OFT progenitors lack both Hand1 and 
Hand2, suggesting that Hand1-mediated compensation does not occur in this cell type. 
Additionally, our analysis of differentially expressed genes between WT and Hand2-null 
AHF, OFT and RV cells indicated that WT cells were enriched in genes that modulate 
normal cellular functions, while Hand2-null cells expressed genes controlling the 
response to hypoxia and apoptosis (Fig. 3.4c). At the time of dissection, Hand2-null 
embryos did not show overt signs of heart failure, such as cardiac edema (Fig. 3.4d), but 







Figure 3.4: Hand1 expression is dysregulated in OFT cells of Hand2-null mutants. 
a, Hand1 and Hand2 expression in LV and OFT cells at E9.25. b, In situ hybridization for 
Hand1 in WT and Hand2-null embryos at E9.25 with quantification. Mean +/- s.e.m is 
indicated. n=3 independent experiments with similar results. c, GO biological process 
terms of differentially expressed genes in WT and Hand2-null AHF, OFT or RV cells at 







3.3 Pseudotime analysis of WT and Hand2-null AHF, OFT and RV cells at E8.25 
OFT and RV progenitors are reportedly derived from different progenitor 
compartments of the AHF that share common ancestry with distinct head muscle 
lineages100. While lineage relationships cannot be inferred through pseudotime analysis, 
we reasoned that differences in cell states between WT and Hand2-null AHF, OFT and 
RV cells would indicate whether and how Hand2 loss differentially impacts RV and OFT 
cell specification. Thus, to test the cell fate determinant prediction, we ordered these cells 
captured at E8.25 in pseudotime (Fig. 3.5 a-d).  The resulting trajectory began with AHF 
cells and split into three cell states: one state primarily comprised OFT cells, while RV 
cells bifurcated into two separate states. Hand2-null cells were severely depleted in the 
OFT State, and while RV State 1 comprised both WT and Hand2-null cells in comparable 
numbers, WT cells predominated in RV State 2. Differential gene expression analysis 
between these two RV states indicated that maturation genes such as Nppa and Nppb 
were highly expressed in the WT-enriched State 2 (Fig 3.5e). These data suggest 
differential perturbations in OFT- and RV-fated cells upon Hand2 loss; whereas OFT cells 
had disrupted specification, RV cells displayed differentiation defects but were 
appropriately specified, consistent with the lineage specifier analysis.  
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Figure 3.5: Hand2 loss disrupts OFT myocardial cell specification and RV 
myocardial cell differentiation.  
a, Pseudotime trajectory of AHF, OFT and RV cells at E8.25 colored by cluster identity, 
b, genotype and c, cell state. n=2 biologically independent embryos per genotype. 
Numbers in b indicate absolute number of cells of each genotype in each cell state. 
Percentages indicate proportions of cells per genotype in each state, graphically 
represented in (d). e, Violin plots showing expression of Nppa and Nppb each RV State. 






3.4 Hand2-null RV cells are present at E9.25 and have defects in migration 
We next asked whether RV cells are retained in Hand2-null embryos at E9.25. 
Indeed, expression overlap between the ventricle gene Irx4 and the RV-enriched Cck 
gene, as well as exclusion of LV genes Hand1 and Cited1, indicated the presence of an 
RV population that comprised Hand2-null cells in comparable numbers to WT (Fig. 3.6a, 
Table 3.1). This suggested that RV cells are present in Hand2-null hearts at this stage, 
despite the absence of the RV chamber. To determine where these RV cells were located 
in the embryo, we performed multiplexed in situ hybridization for Irx4 and Cck transcripts 
on whole-mount embryos at E8.5 and E9.25. These experiments revealed that Irx4+/Cck+ 
RV cells were present and located in the AHF area behind the LV at E8.5 and in the area 
of the OFT at E9.25 (Fig. 3.6b, c). We further validated this result using section analysis 
and in situ hybridization expression analysis for the gene Sema3c in whole-mount 
embryos at E8.5 (Fig. 3.6d, e). Ectopic activation of Sema3c in cardiac neural cells has 
been shown to abrogate their migration into the anterior pole of the heart. The 
upregulation of Sema3c and dysregulation of migration-related genes, such as Ifitm1148, 
Cxcl12149, Syne2150 and Pdpn151, in Hand2-null RV cells at E7.75 and E8.25, suggested 
a migratory defect as the underlying mechanism for the mislocalization of these cells at 
E9.25 (Supplementary Table 3.1). Moreover, the genes Wnt5a and Tbx2 were 
downregulated and ectopically activated, respectively, in Hand2-null RV progenitor cells 
at E7.75 and E8.25 (Fig. 3.6f). Deletion of Wnt5a and misexpression of Tbx2 in the AHF 
have previously been shown to inhibit deployment of AHF cells into the heart tube152,153, 
suggesting their dysregulated expression in Hand2-null RV cells may also contribute to a 
migratory defect.  
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Figure 3.6: Right ventricle cell migration is impaired in Hand2-null embryos.  
a, UMAP plot of subset of cardiac populations captured at E9.25 colored by cluster and 
showing expression domains of Irx4, Cck and Cited1 indicating the presence of LV and 
RV cells. b, Expression of Cck and Irx4 by in situ hybridization in right lateral view to 
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localize RV cells at E8.5 and corresponding fluorescence image for Cck or Irx4 
expression alone. c, Whole-mount in situ hybridization for Irx4 and Cck in right lateral view 
and d, transverse sections at E9.25 indicating presence of RV cells in Hand2 mutants 
(arrowheads). n=2 independent experiments with similar results for b-d. e, Expression of 
Sema3c to localize AHF cells and derivatives at E8.5 in right lateral view with 
quantification of signal. n = 3 independent experiments with similar results. Mean +/- SEM 
is indicated. Scale bars, 200 µm.  f, Violin plots of Wnt5a and Tbx2 expression in WT and 
Hand2-null RV cells at E7.75 and E8.25, respectively.  
 
Our in situ hybridization strategy to identify Hand2-null RV cells with Irx4 and Cck 
probes revealed that these cells were located behind the LV in the area of the OFT region 
at E9.25 (Fig. 3.6c). Given that Cck strongly marks the interventricular septum (IVS), the 
striking lack of Cck expression along the boundary of LV chamber, where the normal IVS 
should morphologically be situated, also indicated that IVS formation was disrupted. This 
is consistent with studies showing that Hand2 function is critical for IVS development154. 
 
3.5 Conclusions and Discussion 
 In this work, we interrogated how loss of Hand2 disrupts the fate and behavior of 
the anterior heart field and its derivatives using single-cell RNA sequencing. We found 
that transcriptional dysregulation of Hand2-null cardiac progenitors occurs as early as 
E7.75, concomitant with the onset of Hand2 expression in the cardiac crescent and prior 
to emergence of a visible morphological defect. To our knowledge, this is the first report 
of the Hand2-null phenotype that investigates the dysregulation of cell types at this early 
stage. The Hand2-null AHF and pSHF populations both displayed delayed differentiation 
kinetics, with the AHF displaying aberrant transcriptional features of the pSHF that 
appears to be mediated by anterior expansion of retinoic acid signaling and subsequent 
posteriorization. Strikingly, consistent with the predictions of our lineage-specifier analysis 
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(Chapter 2), we uncovered that loss of Hand2 perturbs RV and OFT myocardium cells in 
distinct ways; OFT cells fail to become specified while RV cells are appropriately 
specified, but fail to further differentiate and migrate into the heart tube to eventually form 
the RV chamber.  
Since its discovery over twenty years ago, Hand2 has been considered a crucial 
RV gene, due to the dramatic loss of the RV chamber upon its deletion. While our findings 
indicate that Hand2 is indeed critical for RV myocardium differentiation and migration, the 
discovery that Hand2 is important for OFT myocardium specification was previously 
unappreciated. While the important contribution of Hand2 to the formation of the OFT 
structure has been established80,81, the current literature on this has largely focused on 
Hand2 function in cardiac neural crest cells that migrate into the heart to regulate 
morphogenesis and septation of the OFT.  Our work further refines our understanding of 
Hand2 function in these distinct progenitor compartments and sheds light on the 
molecular mechanisms by which Hand2 loss leads to a heart defect.   
A previous study reported ChIP-seq data collected from whole hearts of 
Hand23xFLAG mouse embryos, and defined the genome-wide interaction profile and 
putative transcriptional targets of Hand285.  Many of the genes that neighbored the 
regions bound by Hand2 in this study were transcriptionally dysregulated in the AHF, RV 
and OFT cells in our dataset, including Lefty2, Pitx2, Wnt5a, Tgfb2, Bmp4, Smyd1, Mtus2 
and Rgs5. This provides further support for these genes being bona fide Hand2 targets. 
Other genes that were not identified in this study but were strongly dysregulated in our 
dataset include Tdgf1, Upp1, Sema3c, Cfc1 and Nppa. Hand2 has previously been shown 
to regulate the Nppa gene, but this regulation occurs independently of its DNA-binding 
 59 
activity146. It is possible that strongly dysregulated genes such as Tdgf1, Sema3c and 
Upp1 are similarly regulated by Hand2.  
Several genes encoding regulators of left-right asymmetry were dysregulated in 
Hand2-null AHF, pSHF, OFT and LV, including Nodal, its co-receptor Cfc1, Lefty2 and 
Pitx2 (Supplementary Table 3.1). Intriguingly, the direction of transcriptional 
dysregulation of Pitx2 in distinct compartments was variable; Pitx2 was downregulated in 
the mutant pSHF at E7.75, consistent with the downregulation of Nodal in this domain, 
but was upregulated in the mutant OFT and LV at the same stage. Moreover, Lefty2 was 
upregulated in the mutant AHF and OFT at E7.75, while Cfc1 was downregulated in all 
AHF, pSHF, OFT and LV compartments. Early work on the relationship between Hand2 
and establishment of L/R asymmetry suggested that Hand2 function in the ventricle 
chambers was decoupled from L/R patterning78; our single-cell data indicates that Hand2 
loss does impact expression of mediators of L/R asymmetry signals in the SHF and OFT. 
Whether this transcriptional perturbation reflects purely dysregulated expression of these 
genes as opposed to disruption of the cell populations that express these genes is 
unclear. In an attempt to distinguish between these two possibilities, we subclustered the 
AHF and pSHF populations of WT and Hand2-null embryos to study the 
subcompartments within these domains; however, mapping the Hand2-null populations 
to their WT counterparts was not trivial or fruitful (data not shown). We are currently in the 
process of addressing this with computational methods such as transfer learning155,156. 
Additionally, defining how the spatial distribution of these populations is affected in 
Hand2-null mutants will also yield insights into this question. 
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We observed gene dysregulation in both the AHF and pSHF populations at E7.75, 
however the onset of overt transcriptional perturbation in their respective daughter 
lineages was not synchronous. The AHF-derived OFT and RV myocardium cell 
transcriptomes were dysregulated at E7.75 in Hand2-null mutants, while pSHF-derived 
atrial cells became dysregulated at the heart tube stage at E8.25 (Supplementary Table 
3.1). One possibility for this observation is that the transcriptional consequences of Hand2 
loss in the pSHF are delayed relative to AHF, and might reflect subtle differences in timing 
of Hand2 expression onset in the cardiac crescent. In support of this interpretation, our 
wild-type analysis of CPC populations indicates that at E7.75, the expression levels of 
and proportion of cells expressing Hand2 are higher in the AHF than the pSHF (Fig. 3.7a). 
While we did not observe overt signs of heart failure during dissection of Hand2-
null mutants at E9.25, these embryos were in hypoxic stress based on enrichment of 
genes related to the response to hypoxia and positive regulation of apoptosis. However, 
at earlier stages, we did not find evidence of increased apoptosis, neither transcriptionally 
nor via an increase in contaminating mitochondrial reads157. Although we cannot rule out 
the fact that Hand2 regulates the survival of SHF progenitors, as observed previously at 
E9.25, especially given that cell death pathways are primarily regulated at the post-
translational level158, our transcriptome data suggests that at early stages of 




Figure 3.7: Enriched expression of Hand2 in AHF and broad expression in the 
cardiogenic mesoderm.  
a, Dotplot indicating expression of Hand2 in the AHF and pSHF populations at E7.75. b, 
UMAP plot indicated broad expression of Hand2 in cardiogenic mesoderm.  
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RA abundance and signaling gradients in the developing embryo are governed by 
cell-type-specific enzymatic networks that promote its metabolism and subsequent 
transcriptional signaling or limit its bioavailability by increasing its catabolism159,160. Our 
data indicates that Hand2 loss results in transcriptional dysregulation of genes encoding 
two RA binding proteins with opposing functions and impacts on RA signaling. The pattern 
of dysregulation of these genes suggested that RA signaling is expanded into the Hand2-
null AHF and OFT. Indeed, we validated the anterior expansion of RA with a reporter of 
its transcriptional activity and showed anterior expression of one of its target genes, 
Hoxb1, in the SHF, indicating that the Hand2-null AHF domain is posteriorized.  
It is possible that expanded RA signaling in Hand2-null AHF compartments that 
give rise to the OFT and RV myocardium cells might contribute to the defects we 
observed. This is particularly relevant given that Crabp1 and Crabp2 expression is also 
dysregulated in the OFT and RV myocardium cells at E7.75 (Supplementary Table 3.1) 
and treatment of mouse embryos with exogenous RA at E7.5 abrogates proper formation 
of the OFT and ventricles51. Intriguingly, more recent work demonstrated that exogenous 
RA administration does not impact ventricular specification at the cardiac crescent stage, 
but alters their differentiation161, consistent with our findings in the Hand2-null mutant.  
In order to determine whether blocking the ectopic RA activity in Hand2-null mutant 
embryos would reverse or mitigate the Hand2-null heart defects, we treated embryos 
resulting from a Hand2+/- intercross with the pan-retinoid receptor antagonist, 
AGN193109162 by oral gavage administered to the pregnant female when embryos were 
approximately at the E7.5 stage. While we found that some Hand2-null embryos treated 
with the antagonist exhibited an enlarged OFT region and some dampening of expanded 
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Upp1 expression (data not shown), these phenotypes were highly variable, likely owing 
to the difficulty in consistent timing of antagonist administration between different litters. 
Stringent dissection of whether and how ectopic RA drives the defects will require 
complex genetic crosses. We also cannot rule out that there may be RA-independent, 
Hand2-dependent dysregulation in the AHF, since the expanded expression domain of 
the RA-transcription reporter did not encompass the entire AHF region at E9.25. One 
possibility is that Hand2 might be directly regulating expression of Hoxb1 and Hoxa1, 
since it has been shown to bind genomic regions in the vicinity of these two genes85.  
 Several RA-dependent, Hox gene expressing progenitor subdomains of the pSHF 
contribute to the inferior wall of the OFT that will give rise to the myocardium at the base 
of the pulmonary trunk. These subdomains are defined by distinct and overlapping 
expression of Hoxa1, Hoxb1 and Hoxa3. While Hoxa1 and Hoxb1 appear to be ectopically 
activated in the Hand2-null AHF, we also noted increased Hoxa1 only in the mutant pSHF 
at E9.25. Whether this increase reflects upregulation in endogenous Hoxa1-expressing 
pSHF cells or that this subdomain has expanded merits further scrutiny. Furthermore, 
expression of Tbx1 and Tbx5 were upregulated and downregulated, respectively in the 
pSHF. A potential explanation for this observation is that decreased Tbx5 in the mutant 
pSHF results in failure of Tbx1 downregulation in cells at the AHF-pSHF boundary57. 
Further interrogation of the molecular and spatial heterogeneity of the Hand2-null pSHF 
will clarify whether this dysregulation occurs in the same cell subpopulation. Taken 
together, these data suggest that pSHF patterning may also be disrupted in Hand2-null 
mutant embryos.   
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 We have shown that loss of Hand2, which is broadly expressed in cardiac 
mesoderm derivatives (Fig. 3.7b), causes dysregulation of distinct molecular pathways 
and therefore drives unique functional deficits in cell subpopulations of the developing 
heart. Understanding how Hand2 molecularly regulates these pathways in OFT and RV 
myocardium requires a thorough characterization of its target gene network in each of 
these cell types. This is now technically feasible with the rapidly expanding single-cell 
toolkit, which includes single-cell ATAC-seq, ChIP-seq and protein-DNA interaction 
mapping technologies163–165.  Combining the output of these technologies with single-cell 
RNA sequencing data, including the dataset presented here, will enable us to map the 
chromatin landscape and DNA binding activity of Hand2 in specific cell subtypes and will 
shed light on the longstanding question of how this core cardiac transcription factor 





































4.1 Summary  
In this work, we interrogated the transcriptional dynamics of early normal and 
Hand2-deficient cardiogenesis with scRNA-seq. We uncovered the cellular and 
transcriptional heterogeneity that emerges during normal cardiogenesis and demonstrate 
that these data can be leveraged to uncover novel cell-type-specific fate determinants. 
These data will serve as a valuable resource for the cardiac development community, 
particular when combined with other single-cell modalities, such as scATAC-seq, 
scGESTALT, ChIP-seq and Slide-Seq166,167. Additionally, by applying new computational 
methods for single-cell assays, our understanding of the molecular regulatory logic 
underlying how diverse cardiac cell types are integrated to assemble the heart will 
become clearer and more nuanced. Our analysis of Hand2-deficient cardiogenesis 
demonstrates that scRNA-seq is a potent strategy for dissecting how cell subsets acquire 
distinct functional and specification defects during disrupted organogenesis of a complex 
tissue. Thus single-cell assays will empower us to more effectively determine the cellular 
and molecular pathways underlying phenotypic presentation of congenital defects 
associated with genetic variation.  
  
4.2 Leveraging multi-model single-cell analysis to study cardiac development 
 While scRNA-seq is a powerful methodology, focusing only on gene expression 
dynamics yields an incomplete view of the complexities underlying cardiac development. 
Given that scRNA-seq does not capture epigenetic, lineage and spatial information, 
efforts to combine it with other modalities that focus on these aspects will give us greater 
clarity on the molecular mechanisms that govern heart formation. For example, a study 
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that paired Fluidigm-based scRNA-seq with single-cell ATAC-seq (scATAC-seq) to 
analyze Isl1+ CPCs identified differential transcription factor binding dynamics as these 
progenitors bifurcated to the cardiomyocyte or endothelial cell lineage70. This study also 
demonstrated that scATAC-seq can uncover greater cellular heterogeneity than scRNA-
seq alone, likely owing to the fact that ATAC-seq can identify chromatin remodeling 
changes in transition cell states that do not coincide temporally with transcriptional 
activation or repression.   
 Several questions remain that can be addressed by integrating scRNA-seq and 
ATAC-seq analysis. Differential enhancer usage confers a cell-type-specific regulatory 
code that is not evident at the transcriptional level168,169. Our analysis of LV and RV 
myocardium cells highlighted their remarkably similar transcriptional profiles and 
suggests that these two cell types are more distinct at the level of enhancer usage170,171.  
Similarly, very few genes emerged as specific to the CPC subpopulations that we 
uncovered. Identification of CPC-subtype-specific enhancers will enable a more thorough 
characterization of these populations, and will generate more refined lineage-specific 
tools to define and study the daughter cell-types that are specified from each domain172. 
Thus, combined scRNA-seq and scATAC-seq analysis has immense potential to expand 
the known repertoire of cardiac cell-type-specific features.   
 We and others have demonstrated the utility of constructing cellular differentiation 
trajectories with scRNA-seq data173. While these have revealed key insights about the 
transcriptional drivers of cell states that arise in a differentiating system, the predicted 
trajectories do not reflect true genetic lineage relationships.  In the last several years, 
techniques that unite scRNA-seq and genetic lineage mapping have been developed, 
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which have revealed the rich and complex clonal dynamics of multi-lineage organs174–177. 
Application of these approaches to cardiogenesis will yield insights into longstanding 
questions about the timing of lineage segregation and origins of CPCs. For example, 
there are conflicting reports as to whether the heart and head muscle lineages share a 
common precursor13,14,100. Additionally, the existence of a common precursor for all FHF 
and SHF cells has been hypothesized, but the identity of such as progenitor has remained 
elusive13,178. Moreover, an early Tbx5+/Mef2cAHF+ progenitor pool that contributes to the 
forming IVS has been identified13. The origin of this population, which expresses markers 
of FHF and SHF lineages that are mutually exclusive in other regions of the heart, is 
unclear. Combined single-cell lineage mapping and transcriptome analysis will allow more 
thorough investigation of these questions.    
 Another limitation of scRNA-seq is that spatial information is lost during sample 
preparation, given that cells must be dissociated from their native tissue context for 
capture of individual transcriptomes. Technologies such as spatial transcriptomics, Slide-
seq and Seq-Fish135–137 overcome these technical limitations and represent  an exciting 
conduit of biological discovery. This advance is particularly relevant to embryogenesis, 
where the sample size is exceedingly small and capturing spatial information in a high-
throughput manner is challenging. As discussed in Chapter 2, these methods can be 
applied to determine whether the spatial positioning of endodermal populations 
determines specification of distinct cardiac subtypes from the underlying cardiac 
mesoderm, and to precisely map the embryonic locations of CPC subdomains. Moreover, 
while its clear that myocardium subtypes from different chambers have distinct 
transcriptional signatures, whether there are chamber-specific endocardial, epicardial or 
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fibroblast subpopulations is unclear. Additionally, diverse subpopulations of non-myocyte 
cells that regulate critical functions and homeostasis of cardiomyocytes have been 
identified179. Spatial transcriptomics methods will be able to better define which specific 
non-myocyte subsets interact with distinct cardiomyocyte subpopulations. These 
endeavors will provide novel insights into how the many cell types of the heart converge 
and interact at 3D resolution.  
 
4.3 Novel computational methods to interrogate cardiac development and fate 
 Innovative computational methods for single-cell analyses are rapidly being 
developed and have the potential to expand our understanding of the mechanisms 
underlying cardiogenesis. A recent study utilized scRNA-seq and cell-cell pairing analysis 
to define the signaling interactions between CPCs, and discovered that SHF progenitors 
are guided to the heart tube via Cxcr2/Cxcr4 signaling cues emanating from FHF cells180. 
Application of similar computational strategies181–183 will enable us to comprehensively 
define the range of intricate cell-cell signaling events in cardiac differentiation and 
morphogenesis, including interactions between the endoderm and cardiac cell subsets, 
neural crest cells and the SHF, epicardium and myocardium, and endocardium and 
myocardium6,22,184–186. These efforts will inform strategies to more faithfully recapitulate 
development in a dish and generate stem cell-derived cardiac cell types in vitro that are 
comparable to their in vivo counterparts. 
 Understanding how gene networks are established to specify and maintain the fate 
of cardiac cell subsets is now possible with computational tools such as TransSyn187. This 
method identifies synergistic transcriptional cores that define the identity of a given cell 
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subpopulation. These ‘identity transcription factors (TFs)’ can then be utilized to drive 
transdifferentiation of desired cardiac cell fates from a known starting cell type. The value 
of this approach is that it identifies distinct core TF gene regulatory networks that are 
active in cell subtypes with highly similar transcriptional signatures. In the long term, 
applying this transdifferentiation strategy may be a viable clinical intervention for CHD.  
For example, the LV and RV chambers perform physiologically distinct roles and are 
differentially impacted in CHD, despite having highly similar transcriptional signatures in 
vivo. The CHD called Hypoplastic Left Heart Syndrome (HLHS), in which the left ventricle, 
mitral valve and aortic valve are underdeveloped, comprises 1.4-3.8% of CHDs; yet 
despite this relatively low incidence, HLHS is responsible for 23% of cardiac deaths 
occurring in the first week of life188. Thus, there is a critical need for strategies to combat 
this devastating condition, and one such approach is to convert cells of the RV to take on 
a more LV-like identity and physiology that can support systemic circulation.  
To this end, our lab is currently testing the TransSyn computational approach in 
collaboration with Dr. Satoshi Okawa and Dr. Antonio del Sol at the University of 
Luxembourg. Our preliminary goal is to convert in vitro human iPS-derived SHF cells and 
RV cardiomyocytes to FHF cells and LV cardiomyocytes, respectively. In our hands, 
human iPS-derived CPCs and cardiomyocytes resemble the SHF and SHF-derived RV 
cells, respectively. We applied the TransSyn method to our mouse embryonic LV, RV, 
FHF and AHF cells (chapter 2) and identified Hand1, Cited1, Tbx20, Hmgb2, Mef2c, Ybx1 
and Btf3 as core identity TFs of LV cells, while Hand1, Smarcd3, Gata5, Hoxb2, Morf4l2 
and Ddx5 were determined as identity TFs of FHF cells. We are currently testing a 
combinatorial strategy in which we infect iPS-CPCs, which have an SHF signature, with 
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combinations of FHF identity TFs in order to obtain functional FHF cells that can 
differentiate into LV cells. We are also implementing this strategy with iPS-CM, which 
have an RV identity, to more directly obtain iPS-CMs with an LV identity. If these efforts 
prove to be successful, our next step is to test the possibility of achieving this conversion 
in vivo. This work will lay the foundation for developing cardiac cell conversion strategies, 
with profound implications for our ability to treat CHD.  
 
4.4 Harnessing scRNA-seq to understand and overcome CHDs 
 Single-cell transcriptomics enabled us to uncover how loss of Hand2 leads to cell-
type-specific perturbations resulting in a complex developmental defect. These features 
remained undiscovered due to relatively few cells being affected, particularly at early 
developmental stages, and likely were revealed by our ability to interrogate tens of 
thousands of cells in the heart. Previous studies of human patient cohorts have identified 
damaging loss-of-function mutations in Hand2 that are associated with CHDs such as 
ventricular septal defects and Tetralogy of Fallot189–192. Our work presents a foundation 
for interrogating how such mutations could result in these heart malformations.  
Future studies should also investigate how increased Hand2 dosage causes 
congenital defects. One study discovered that duplication of the Hand2 gene is a major 
cause for the limb and heart phenotypes of the chromosomal disorder partial trisomy 
distal 4q193.  Additionally, our scRNA-seq analyses of the transcriptional changes induced 
by trisomy 21, the genetic condition also known as Down Syndrome (DS), reveal 
upregulated Hand2 expression and concomitant dysregulation of genes such as Upp1, 
Crabp1 and Crabp2 (Sanjeev Ranade, Unpublished observation). This dysregulated 
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gene signature manifests in Rspo3+ AVC and OFT myocardium cells in a mouse model 
of DS as well in iPS-derived cardiomyocytes that originated from a human DS patient. 
Thus, uncovering the mechanisms by which ectopic Hand2 expression disrupts the fate 
and behavior of these specific cell types will advance our understanding of how these 
genetic lesions cause developmental anomalies.    
The scRNA-seq approach enabled us to glean novel, precise insights about the 
Hand2-null phenotype in a mouse model of cardiac development. Many core cardiac 
transcription factors, such as NKX2-5, GATA4, MEF2C, TBX5, HAND1, TBX1 and ISL1, 
are broadly expressed in overlapping and complementary cell populations of the heart, 
and are causative agents of numerous CHD phenotypes when mutated6. Dissecting the 
loss of function phenotypes of these critical genes with the single-cell modalities 
described is likely to reveal novel mechanisms underlying their biology. Moreover, 
constructing an integrated view of how these transcriptional regulators coordinately 
orchestrate cardiac morphogenesis is now possible. For example, independent loss of 
Hand2, Isl1 and Smyd1 gene function leads to abrogated formation of the RV 
chamber18,140. Investigating the convergence and divergence of the molecular 
mechanisms by which loss of these genes leads to this shared defect will yield a broader, 
more detailed understanding of how they synergistically and uniquely regulate RV 
chamber formation.   
Ongoing whole-exome sequencing studies of CHD proband-parent trios are 
identifying damaging inherited variants in novel genes with unknown cardiac 
functions5,194–196. Our dataset serves as a critical resource of cell transcriptomes that can 
be interrogated to define the cell subtypes in which these novel genes function. Several 
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high-resolution catalogs of mouse and human cardiac cell types that emerge and function 
at later stages of heart formation are being reported71,197–199. Combining our dataset with 
these resources will yield a powerful tool that the cardiac development field is poised to 
wield in the quest to uncover the genetic and mechanistic underpinnings of CHD. This is 
a prerequisite for defining preventative approaches and postnatal intervention strategies 































































Animal studies were conducted in strict compliance with all relevant ethical 
regulations in the animal use protocols, UCSF animal use guidelines and the NIH Guide 
for the care and Use of Laboratory Animals. All protocols concerning animal use were 
approved by the Institutional Animal Care and Use Committee (IACUC) at UCSF and 
were accredited by the Association for Assessment and Accreditation of Laboratory 
Animal Care (AAALAC). Transcriptomes were captured from wildtype (WT) and Hand2-
null embryos from intercrossed C57BL/6 mice heterozygous for the Hand2-null allele. 
The sexes of all embryos used for capture of single-cell transcriptomes are listed in 
Table 5.1. Lineage tracing of Cck expressing cells was performed using Cck-Ires-Cre 
(JAX stock #012706)200 and Ai14 (JAX stock #007914)201 mice. Validation of ectopic RA 
signaling in the Hand2 mutant was done by crossing the mutant line to RARE- 
hsp68LacZ mice (JAX stock #008477)202. 
Timed matings between male (8-10 weeks of age) and female (6-8 weeks of age) 
mice were set up where noon on the day of plug detection was considered E0.5. 
Pregnant females were identified by echocardiography performed at E6.5 and sacrificed 
to harvest embryos at E7.75, E8.25 and E9.25 for scRNA-seq and at E7.75, E8.25, E8.5 
and E9.25 for whole mount and section-based in-situ hybridization experiments. 
Transcriptomes from at least 2 embryos were collected per embryonic stage, per 
genotype (Table 5.1). The sample sizes of embryos used for single-cell transcriptome 
analysis at each time point was chosen to obtain cell numbers comparable to estimated 
cell numbers in the cardiogenic region at each embryonic stage. Embryos were 
developmentally matched at each time point by somite count.  
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Randomization was not implemented; experimental groups were determined by 
genotype i.e., Hand2 wild type embryos were compared to Hand2-null embryos. 
Covariates were not relevant to the analysis of the Hand2-null phenotype as the 
developmental defect is highly penetrant regardless of embryo sex, and the 
developmental stages analyzed were prior to the onset of overt heart failure. 
Investigators were not blinded to allocation of embryos during experiments. Blinding was 
not possible for the WT and Hand2-null embryo comparisons due to the need to match 
somite counts to control for developmental timing. 
 
Embryo dissection and single-cell library generation 
The entire cardiogenic region was dissected at each time point, including the SHF 
region that lies behind the cardiac crescent and heart tube, as well as the first and 
second pharyngeal arches at E9.25. Due to the small size of embryos at these stages, 
some surrounding tissue (indicated in Fig. 2.1, Chapter 2) encompassing the posterior 
lateral plate mesoderm (E7.75), head folds (E7.75 and E8.25), and endoderm, was 
microdissected to ensure complete retrieval of cardiac populations. Embryos were 
dissected in cold PBS (Life Technologies, CAT# 14190250), de-yolked and placed in 
PBS/1% FBS (ThermoFisher Scientific, CAT# 10439016) solution on ice until dissociation 
(approximately 3 hours). Yolk sac DNA was extracted (QuickExtract DNA Extraction 
Solution, Epicentre, CAT# QE09050) and used for genotyping to distinguish Hand2 WT 
and Hand2-null embryos before further microdissection of cardiac regions at each stage. 
Dissected cardiac tissue was incubated in 200 µl TrypLE (ThermoFisher Scientific, CAT# 
12563029) for 5 min, triturated with a 200 µl pipette tip, and incubated for an additional 
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5 min. The TrypLE solution was quenched with 600 µl PBS/1% FBS. Cells were filtered 
through a 70 µm cell strainer (BD Falcon, CAT# 08-771-2), centrifuged at 150 rcf for 3 
min, and resuspended in 35 µl PBS/1% FBS. Single-cell droplet libraries from this 
suspension were generated in the 10X Genomics Chromium controller according to the 
manufacturer’s instructions in the Chromium Single Cell 3′ Reagent Kit v2 User Guide. 
The cell capture efficiency of the Chromium controller is ~57%, thus, we loaded all cells 
dissected from embryos without pre-counting, to minimize cell loss and maximize the 
number of captured single cells. Additional components used for library preparation 
include the Chromium Single Cell 3′ Library and Gel Bead Kit v2 (PN-120237) and the 
Chromium Single Cell 3′ Chip kit v2 (PN-120236). 
 
Single cell library preparation and sequencing 
Libraries were prepared according to the manufacturer’s instructions using the 
Chromium Single Cell 3′ Library & Gel Bead Kit v2 (PN- 120237) and Chromium i7 
Multiplex Kit (PN-120262). Final libraries were sequenced on the NextSeq 500 and 
Hiseq 4000. Somite-matched WT and Hand2-null replicate libraries from each litter were 
pooled and sequenced in the same lane (Table 5.2). Sequencing parameters were 
selected according to the Chromium Single Cell v2 specifications. All libraries were 
sequenced to a mean read depth of at least 50,000 total aligned reads/cell (Table 5.3). 
 
Processing of sequencing data 
Raw sequencing reads were processed using the Cell Ranger v2.2.0 pipeline from 
10X Genomics. Briefly, reads were demultiplexed, aligned to the mouse mm10 genome 
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and UMI counts were quantified per gene per cell to generate a gene-barcode matrix 
(Table 5.4). Data from multiple samples (WT only analysis, WT/Hand2-null E7.75/E8.25 
and WT/Hand2-null E9.25 analyses) were aggregated and normalized to the same 
sequencing depth, resulting in a combined gene-barcode matrix of all samples. 
 
Cell filtering and cell-type clustering analysis 
We sequenced the transcriptomes of 36,777 cells captured from WT and 37,149 
cells captured from Hand2-null embryos in total (Table 5.1). Further filtering and 
clustering analyses of these cells were performed with the Seurat v2.2 R package, as 
described in the tutorials (http://satijalab.org/seurat/). For each aggregated dataset (WT 
only, WT/Hand2-null E7.75/E8.25, WT/Hand2-null E9.25), cells were normalized for 
genes expressed per cell and total expression, then multiplied by a scale factor of 10,000 
and log-transformed. Cells that were of low quality or represented doublets were 
excluded from our analyses - this was achieved by filtering out cells with greater than 
8000 and fewer than 1500 genes in Seurat (Table 5.5). We then performed a linear 
regression on all genes to eliminate technical variability due to the number of genes 
detected, embryonic time point, embryo replicate and stage of the cell cycle (ScaleData 
Function). For the Hand2-null analyses, we also regressed out the Hand2 gene to 
eliminate its contribution to cell clustering. Highly variable genes in the dataset were 
computed and used as input for Principal Component Analysis. Significant PCs were 
used for downstream graph-based, semi-unsupervised clustering into distinct 
populations (FindClusters Function) and Uniform Manifold Approximation and Projection 
(UMAP) dimensionality reduction was used to project these populations in 2D203. For 
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clustering, the resolution parameter, which indirectly controls the number of clusters, was 
approximated based on the number of cells according to Seurat guidelines; a vector of 
resolution parameters was passed to the FindClusters function and the optimal 
resolution that established discernible clusters with distinct marker gene expression was 
selected. One or two cell clusters would emerge that expressed marker genes 
representing multiple populations; these contained cells with low UMI and gene counts 
that escaped the first filtering step. These cells were removed from the analyses. To 
identify marker genes, the clusters were compared pairwise for differential gene 
expression using the Wilcoxon rank sum test for single-cell gene expression 
(FindAllMarkers function, min.pct = 0.25, min.diff.pct = 0.1, return.thresh (p-value cut-
off) = 1x10-4). To assign identities to these subpopulations, we cross-referenced their 
marker genes with known cardiac subtype markers and in situ hybridization data from 
the literature (Supplementary Table 2.1). We also validated several of these marker 
genes by fluorescence in situ hybridization (Fig. 2.4). We removed blood, endoderm-, 
and ectoderm- derived clusters based on their expression of known blood markers such 
as the hemoglobin genes, endoderm markers such as Epcam and Foxa2, and ectoderm 
markers such as Pou3f1 and Sox2 (Fig. 2.2c), retaining the cells of mesodermal or 
neural crest identity. The clustering approach was then repeated for these retained 
mesodermal and neural crest cells, beginning with the regression of technical variables, 
identification of highly variable genes, Principal Component Analysis, graph-based 
clustering, UMAP projection and marker analysis. Similarly, all reclustering analyses 
(Fig. 2.3) were processed as described above. For computing differentially expressed 
genes between Pitx2-positive (normalized UMI >0.1) and Pitx2-negative (normalized 
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UMI < 0.1) cells in clusters A and I (Fig. 2.9a) and for the Hand2-null analyses, the 
FindMarkers function was used on WT and Hand2-null cells from each cluster with the 
following parameters: Wilcoxon rank sum test, min.diff.pct = 0.1, min.pct = 0.25, 
logFC.threshold = 0.2. Additionally, the max.cells.per.ident argument was used to ensure 
that equivalent numbers of cells were considered in the analysis. For each population 
analyzed, the number of cells (n) given to this argument was set to the 
population/genotype that had the lower cell number. An adjusted p-value (Bonferroni 
Correction) cut-off < 1x10-4 was used to identify differentially expressed genes.  
 
Prediction of cell fate determinants 
Cell fate determinants for OFT and RV from the AHF were predicted using a 
modified version of the method that we previously developed. This procedure was 
performed on E7.75 and E8.25 WT OFT, RV and AHF cells. One hundred cells were 
randomly selected from the AHF and from the OFT and RV daughter populations and 
the normalized ratio difference (NRD) was computed for all combinations of these 100 
cells, yielding 10,000 parent-daughter cell combinations. The NRD was calculated for all 
pairs of differentially expressed TFs between OFT, RV and AHF cells and averaged over 
the 10,000 cell combinations. We minimized the impact of zero inflation by relying on the 
highly stringent adjusted (Bonferroni) p-value cutoff (< 1x10-4) and by filtering out very 
lowly expressed genes in defining differentially expressed TFs (average expression >= 
0.5 normalized UMI). We filtered out genes that were detected in less than 25% of cells 
in populations being compared, and only tested genes that show a minimum difference 
of 0.1 in the fraction of detection between the two groups. TF pairs whose mean NRD 
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was more than 0.05 in one lineage direction but less than 0.01 in the other lineage 
direction were selected. Finally, the TF pairs that resided in the strongly connected 
component of the GRN were kept as the final candidate cell fate determinants. 
 
Cell trajectory analysis 
Pseudotime analyses were performed using the Monocle 2 package, as 
described in the tutorials (http://cole-trapnell-lab.github.io/monocle-release/). 
Differentially expressed genes, as determined in Seurat using the FindAllMarkers 
function, between the myocardium, CPC and WT/Hand2-null AHF, OFT and RV cells 
were used as input for temporal ordering of these cells along the differentiation trajectory. 
 
In situ hybridization experiments 
Each in situ hybridization experiment was replicated at least twice for identifying 
spatial expression of genes and three times for quantification of in situ signal for 
differentially expressed genes in the Hand2-null analysis. For whole-mount experiments: 
de-yolked whole embryos were fixed in a 4% formaldehyde solution (ThermoFisher 
Scientific, CAT# 28906) overnight at 4°C followed by 2X PBST washes and 5-minute 
incubations in a dehydration series of 25%, 50%, 75% and 100% methanol (Fisher 
Scientific, CAT# A454-1). At this point embryos were stored in 100% methanol at -20°C 
until the in situ protocol was initiated. Yolk sac DNA was used for genotyping. The whole-
mount in situ assay was adapted from the protocol formulated for whole-mount zebrafish 
embryos204 using the RNAscope Multiplex Fluorescent Reagent Kit v2 (Advanced Cell 
Diagnostics, CAT# 323100), with minor modifications (the air-drying step was excluded 
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in our protocol, Protease Plus was used for embryo permeabilization, and the 0.2X SSCT 
wash step between reagent incubations was reduced to 3X 8 mins). Whole-mount 
embryos were imaged in 0.1% PBST using the Leica M165 fluorescent dissecting scope 
(FC/PLANAPO 1.0x #10450028; Camera – DFC3000G; ET GFP #10447408, ET 
mCHER #10450195, Acquisition Software – LAS V4.6). Quantification of transcript signal 
from whole-mount WT and Hand2-null embryos was performed using ImageJ v1.51m9. 
The mean grey value and integrated density of a defined area, that was kept consistent 
between WT and mutant embryos, as well as the background fluorescence level for the 
same defined area per embryo was measured. The corrected total fluorescence (CTF) 
for each gene was calculated using the following formula: Integrated density – (Area x 
Background fluorescence). CTF values were the log10 transformed before t-tests were 
conducted to satisfy prerequisite assumptions of normality.  
For in situ hybridization experiments performed on embryo and postnatal day 1 
(p1) heart sections: embryos and p1 hearts were washed 3X in PBS after overnight 
fixation in 4% formaldehyde and stored in 70% ethanol (VWR, CAT# 89125-186) 
indefinitely until embedding. Embryos were embedded in Histogel (Thermo Scientific, 
CAT# R904012) and paraffin processed using standard protocols and embedded for 
transverse sectioning, while p1 hearts were directly processed in paraffin. Tissue slices 
were serially sectioned at 5 µm intervals, mounted on slides and stored at room 
temperature until initiation of the RNAscope protocol for paraffin embedded sections 
(User manual catalog number 322452-USM). Sections were imaged with a Zeiss Axio 
Observer.Z1 inverted epifluorescence microscope (Carl Zeiss Microscopy, Thornwood, 
NY) with Zeiss Axiocam MRm and PCO.edge sCMOS (PCO.Imaging, Kelheim, 
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Germany) monochrome cameras run by Zeiss Zen imaging software. For 3D expression 
reconstruction, embryos were embedded in low melting agarose and imaged with a Zeiss 
lightsheet Z.1 selective plane illumination microscope (Carl Zeiss Microscopy) with 488nm 
and 561nm lasers, tandem PCO.edge sCMOS cameras and Zeiss Zen imaging 
software. 3D reconstructions of multi-view images were performed using Bitplane Imaris 
software v.9.0.2 (Andor Technology PLC).  
Catalog numbers for RNAscope probes used: Cck, 402271-C3; Cited1, 432471; 
Hand1, 429651-C2; Irx4, 504831; Pln, 506241; Rgs5, 430181; Sema3c, 441441-C3; 
Tdgf1, 506411; Tbx5, 519581-C2 and Upp1, 504841-C2; Tbx1, 481911-C2; Nr2f2, 
480301-C3; Hoxb1, 541861; LacZ, 313451; Tbx18, 515221-C2; Mab21l2, 456901; 
Wnt5a, 316791; Bmp4, 401301- C2; 3632451O06Rik, 502031; C130080G10Rik, 
506051; Tnnt2, 418681-C4; Actc1, 510361-C2; Cacna2d2, 449221-C2; Tbx2, 448991-
C2; Shox2, 554291-C3; TdTomato, 317041-C2. 
 
Statistics and reproducibility 
Standard statistical analyses were performed using GraphPad Prism 8. The 
number of replicates for each experiment are described in the figure legends. All 
differentially expressed genes were calculated using the Wilcoxon rank sum test (two-
sided) and a Bonferroni correction adjusted p-value < 1x10-4 was considered statistically 
significant. The level of significance in all graphs is represented as follow: *P<0.05 and 
**P<0.01. For fluorescence quantification, corrected total fluorescence values were log 
transformed before t-tests were conducted to satisfy the prerequisite assumptions of 
normality. For all quantifications, the mean +/- s.e.m is reported. DAVID v6.8 was used 
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for GO term enrichment analysis; significant functional enrichment was statistically 
determined using a modified Fisher’s exact test (EASE score) followed by Benjamini-
Hochberg correction for multiple comparisons, with 0.01 as a p-value cut-off. No 
experimental samples were excluded from the statistical analyses. Sample size was not 
pre- determined through power calculations, and no randomization or investigator 
blinding approaches were implemented during the experiments and data analyses. 
When representative results are presented to indicate expression patterns of genes in 
WT embryos, at least two independent embryos were analyzed. 
 
Data availability 
All source data, including sequencing reads and single-cell expression matrices 
were deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO 
series accession number GSE126128. Data underlying each figure are available in the 
Supplementary Tables and on the UCSC cell browser at https://mouse-
cardiac.cells.ucsc.edu. Users can use the cell browser to explore the data, view 
expression of genes of interest in each UMAP plot and download datasets for custom 










Table 3.1: Breakdown of cell proportions per genotype, per embryonic stage for 






















































































































































Table 5.1: Sample features in single-cell RNA sequencing experiments 
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E7.75 WT  
E7.75 WT   
E7.75 Hand2-KO  
E7.75 Hand2-KO  
E7.75 Hand2-KO  
 
E8.25 WT  
E8.25 WT  
E8.25 Hand2-KO  
E8.25 Hand2-KO  
 
E9.25 WT  
E9.25 WT  
E9.25 Hand2-KO  
E9.25 Hand2-KO  










































































































Table 5.3: Median reads, genes and UMI counts per cell per sample 
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Table 5.5: Number of cells in each germ lineage per sample after quality control 
  
Embryonic Stage and 
Genotype 
# Endoderm  
Cells 
 
# Ectoderm  
Cells 
 




E7.75 WT  
E7.75 WT  
E7.75 WT  
E7.75 WT  
E7.75 WT   
E7.75 Hand2-KO  
E7.75 Hand2-KO  
E7.75 Hand2-KO  
 
E8.25 WT  
E8.25 WT  
E8.25 Hand2-KO  
E8.25 Hand2-KO  
 
E9.25 WT  
E9.25 WT  
E9.25 Hand2-KO  
E9.25 Hand2-KO  














































































Supplementary Table 2.1 - 
https://www.dropbox.com/s/vidihu63froin0u/Supplementary%20Table%202.1.xlsx?dl=0 
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